Medizinische Universität Graz - Research portal

Navigation/Search

• Researchers.
  • Curriculum.
  • Publications.
  • Projects.
  • Presentations.
  • Advised theses.
• Institutions.
• Projects.
• Publications.
• Partners.
• Sponsors.
• Equipment.
• Knowhow.
• Fields of Research.

Gerger Armin |

** = Publications listed in SCI/SSCI/Pubmed

2023

Full paper/article (Journal)

** Terbuch, A; Walser, G; Stotz, M; Gerger, A; Posch, F; Bauernhofer, T Primary Thromboprophylaxis and the Risk of Venous Thromboembolic Events in Patients With Testicular Germ Cell Tumors Treated With Cisplatinum-Based Chemotherapy.
Clin Genitourin Cancer. 2023; 21(1):24-31 Doi: 10.1016/j.clgc.2022.10.005
Web of Science PubMed FullText FullText_MUG

 

Editorial

** Gerger, A Colorectal cancer special, part 1
MEMO-MAG EUR MED ONC. 2023; 16(1): 2-2. Doi: 10.1007/s12254-022-00866-x
Web of Science FullText FullText_MUG

 

2022

Full paper/article (Journal)

** Barth, DA; Stanzer, S; Spiegelberg, J; Bauernhofer, T; Absenger, G; Posch, F; Lipp, R; Halm, M; Szkandera, J; Balic, M; Gerger, A; Smolle, MA; Hutterer, GC; Klec, C; Jost, PJ; Kargl, J; Stradner, M; Pichler, M Evaluation of autoantibodies as predictors of treatment response and immune-related adverse events during the treatment with immune checkpoint inhibitors: A prospective longitudinal pan-cancer study.
Cancer Med. 2022; 11(16):3074-3083 Doi: 10.1002/cam4.4675 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Barth, DA; Stanzer, S; Spiegelberg, JA; Bauernhofer, T; Absenger, G; Szkandera, J; Gerger, A; Smolle, MA; Hutterer, GC; Ahyai, SA; Madl, T; Posch, F; Riedl, JM; Klec, C; Jost, PJ; Kargl, J; Stradner, MH; Pichler, M Patterns of Peripheral Blood B-Cell Subtypes Are Associated With Treatment Response in Patients Treated With Immune Checkpoint Inhibitors: A Prospective Longitudinal Pan-Cancer Study.
Front Immunol. 2022; 13: 840207 Doi: 10.3389/fimmu.2022.840207 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Gerger, A; Eisterer, W; Fuxius, S; Bastian, S; Koeberle, D; Welslau, M; Sanoyan, DA; Maas, C; Uhlig, J; Fenchel, K; Greil, R; VON, DER, Heyde, E; Agocs, GR; Weide, R; Schwager, M; Reichenbach, F; Modest, DP; Fritsch, R Retrospective Analysis of Treatment Pathways in Patients With BRAF^V600E-mutant Metastatic Colorectal Carcinoma - MORSE^CRC.
Anticancer Res. 2022; 42(10):4773-4785 Doi: 10.21873/anticanres.15982
Web of Science PubMed FullText FullText_MUG

 

** Maisel, F; Smolle, MA; Mollnar, S; Riedl, JM; Barth, DA; Seles, M; Terbuch, A; Rossmann, CH; Eisner, F; Mannweiler, S; Hutterer, G; Zigeuner, R; Pummer, K; Smolle-Jüttner, FM; Lindenmann, J; Stotz, M; Gerger, A; Jost, PJ; Bauernhofer, T; Pichler, M; Posch, F Benefit of Metastasectomy in Renal Cell Carcinoma: A Propensity Score Analysis.
Clin Genitourin Cancer. 2022; 20(4):344-353 Doi: 10.1016/j.clgc.2022.03.010
Web of Science PubMed FullText FullText_MUG

 

** Prinz, F; Jonas, K; Balihodzic, A; Klec, C; Reicher, A; Barth, DA; Riedl, J; Gerger, A; Kiesslich, T; Mayr, C; Rinner, B; Kargl, J; Pichler, M MicroRNA mimics can distort physiological microRNA effects on immune checkpoints by triggering an antiviral interferon response.
RNA Biol. 2022; 19(1):1305-1315 Doi: 10.1080/15476286.2022.2152978 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Riedl, JM; Schwarzenbacher, E; Moik, F; Horvath, L; Gantschnigg, A; Renneberg, F; Posch, F; Barth, DA; Stotz, M; Pichler, M; Hatzl, S; Fandler-Höfler, S; Gressenberger, P; Gary, T; Jost, PJ; Greil, R; Ay, C; Djanani, A; Gerger, A; Schlick, K Patterns of Thromboembolism in Patients with Advanced Pancreatic Cancer Undergoing First-Line Chemotherapy with FOLFIRINOX or Gemcitabine/nab-Paclitaxel.
Thromb Haemost. 2022; 122(4):633-645 Doi: 10.1055/a-1548-4847
Web of Science PubMed FullText FullText_MUG

 

Abstract (Journal)

** Bonnin-Gruber, Y; Schroder, J; Forstbauer, H; Kisro, J; Welslau, M; Muller-Huesmann, H; Burkle, D; Krammer-Steiner, B; von der Heyde, E; Reichenbach, F; Arnold, D; Fritsch, R; Gerger, A; Hegewisch-Becker, S; Vogel, A; Winder, T; Koeberle, D; Prager, G; Stintzing, S Patient characteristics at baseline in the BERING CRC study: real-world data on BRAF V600E-mutated metastatic colorectal cancer
ONCOL RES TREAT. 2022; 45(SUPPL 2): 315-316. [Poster]
Web of Science

 

** Heinemann, V; von Weikersthal, LF; Fuchs, M; Kaiser, F; Heinrich, K; Modest, D; Hofheinz, R; Decker, T; Gerger, A; Angermeier, S; Rumpold, H; Dickhut, A; Ohler, L; Grunberger, B; Niedersuss-Beke, D; Sandmann, M; Kasper, S; Prager, G; Stintzing, S FIRE-4 (AIO-KRK-0114): Randomized study for a switch maintenance concept with 5-FU plus bevacizumab after induction treatment with FOLFIRI plus cetuximab versus continued treatment with FOLFIRI plus cetuximab - secondary endpoint
ANN ONCOL. 2022; 33: S363-S364. Doi: 10.1016/j.annonc.2022.04.415 [Poster]
Web of Science FullText FullText_MUG

 

** Prager, G; Hubner, G; Schroder, J; Forstbauer, H; Kisro, J; Welslau, M; Burkle, D; Von der Heyde, E; Muller-Huesmann, H; Krammer-Steiner, B; Hering-Schubert, C; Popper, U; Gerger, A; Greil, R; Reichenbach, F; Arnold, D; Fritsch, R; Hegewisch-Becker, S; Vogel, A; Wagner, AD; Winder, T; Koeberle, D; Stintzing, S Encorafenib and cetuximab in patients with metastatic, BRAF V600E-mutated, colorectal carcinoma: a multi-centric, multi-national, prospective, non-interventional study in Germany, Austria and Switzerland - BERING CRC
ONCOL RES TREAT. 2022; 45(SUPPL 3): 64-64. [Poster]
Web of Science

 

** Riedl, JM; Barth, D; Steinlechner, S; Moik, F; Posch, F; Schlintl, V; Mayer, MC; Sandner, AM; Berton, F; Koch, L; John, N; Wurm, R; Pichler, M; Absenger, G; Jost, PJ; Wohlkonig, C; Richtig, E; Winder, T; Gerger, A; Terbuch, A Early CRP Kinetics after Initiation of Immune Checkpoint Inhibitors is a predictive Biomarker for Treatment Response independent of the Tumor Antity
ONCOL RES TREAT. 2022; 45(SUPPL 2):228-228.-Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie; Okt 7-10, 2022; Wien. [Poster]
Web of Science

 

** Stintzing, S; Hubner, G; Schroder, J; Forstbauer, H; Kisro, J; Welslau, M; Muller-Huesmann, H; Burkle, D; Krammer-Steiner, B; von der Heyde, E; Reichenbach, F; Arnold, D; Fritsch, RM; Gerger, A; Hegewisch-Becker, S; Vogel, A; Wagner, AD; Winder, T; Koeberle, D; Prager, G Baseline characteristics of patients enrolled in the BERING CRC study: A European real-world study in BRAF V600E-mutant metastatic colorectal cancer.
J CLIN ONCOL. 2022; 40(16): E15584-E15584. [Poster]
Web of Science

 

** Stintzing, S; Von Weikersthal, L; Fuchs, M; Kaiser, F; Heinrich, K; Modest, DP; Hofheinz, R; Decker, T; Gerger, A; Angermeier, S; Rumpold, H; Dickhut, A; Ohler, L; Gruenberger, B; Niedersuess-Beke, D; Sandmann, M; Winder, T; Kasper, S; Prager, G; Heinemann, V Randomized study to investigate a switch maintenance concept with 5-FU plus bevacizumab after FOLFIRI plus cetuximab induction treatment versus continued treatment with FOLFIRI plus cetuximab: Report of a secondary endpoint of the phase-III FIRE-4 study (AIO KRK-0114).
J CLIN ONCOL. 2022; 40(16): [Poster]
Web of Science

 

** Terbuch, A; Walser, G; Stotz, M; Gerger, A; Posch, F; Bauernhofer, T Thromboprophylaxis and its influence on the risk of thromboembolism in patients with germ cell tumors receiving cisplatin-containing chemotherapy
ONCOL RES TREAT. 2022; 45(SUPPL 2):322-322. [Poster]
Web of Science

 

** von der Heyde, E; Burkle, D; Forstbauer, H; Hubner, G; Schmidt, B; Schroder, J; Distelrath, A; Wierecky, J; Stubs, P; Kisro, J; Welslau, M; Muller-Huesmann, H; Gohler, T; Krammer-Steiner, B; Schwaner, I; Hering-Schubert, C; Gerger, A; Greil, R; Jacobasch, L; Reichenbach, F; Stintzing, S; Prager, G Encorafenib and cetuximab in patients with metastatic, BRAF V600E-mutated, colorectal cancer: Update on the first real-world study in Germany and Austria BERING CRC
ANN ONCOL. 2022; 33: S248-S248. Doi: 10.1016/j.annonc.2022.04.099 [Poster]
Web of Science FullText FullText_MUG

 

2021

Full paper/article (Journal)

** Mollnar, S; Pondorfer, P; Kasparek, AK; Reinisch, S; Moik, F; Stotz, M; Halm, M; Szkandera, J; Terbuch, A; Eisner, F; Gerger, A; Kapp, KS; Partl, R; Vasicek, S; Weiland, T; Pichler, M; Stöger, H; Thurnher, D; Posch, F Decrease in treatment intensity predicts worse outcome in patients with locally advanced head and neck squamous cell carcinoma undergoing radiochemotherapy.
Clin Transl Oncol. 2021; 23(3):543-553 Doi: 10.1007/s12094-020-02447-y [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Müller, M; Posch, F; Kiem, D; Barth, D; Horvath, L; Stotz, M; Schaberl-Moser, R; Pichler, M; Greil, R; Jost, PJ; Seeber, A; Amann, A; Schlick, K; Gerger, A; Riedl, JM Benefit of second-line therapy for advanced esophageal squamous cell carcinoma: a tri-center propensity score analysis.
Ther Adv Med Oncol. 2021; 13: 17588359211039930 Doi: 10.1177/17588359211039930 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Posch, F; Prinz, F; Balihodzic, A; Mayr, C; Kiesslich, T; Klec, C; Jonas, K; Barth, DA; Riedl, JM; Gerger, A; Pichler, M MiR-200c-3p Modulates Cisplatin Resistance in Biliary Tract Cancer by ZEB1-Independent Mechanisms.
Cancers (Basel). 2021; 13(16): Doi: 10.3390/cancers13163996 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Prager, GW; Oehler, L; Gerger, A; Mlineritsch, B; Andel, J; Petzer, A; Wilthoner, K; Sliwa, T; Pichler, P; Winder, T; Heibl, S; Gruenberger, B; Laengle, F; Hubmann, E; Korger, M; Pecherstorfer, M; Djanani, A; Neumann, HJ; Philipp-Abbrederis, K; Wöll, E; Trondl, R; Arnold-Schrauf, C; Eisterer, W Comparison of nab-paclitaxel plus gemcitabine in elderly versus younger patients with metastatic pancreatic cancer: Analysis of a multicentre, prospective, non-interventional study.
Eur J Cancer. 2021; 143:101-112 Doi: 10.1016/j.ejca.2020.11.003 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Riedl, JM; Hasenleithner, SO; Pregartner, G; Scheipner, L; Posch, F; Groller, K; Kashofer, K; Jahn, SW; Bauernhofer, T; Pichler, M; Stöger, H; Berghold, A; Hoefler, G; Speicher, MR; Heitzer, E; Gerger, A Profiling of circulating tumor DNA and tumor tissue for treatment selection in patients with advanced and refractory carcinoma: a prospective, two-stage phase II Individualized Cancer Treatment trial.
Ther Adv Med Oncol. 2021; 13:1758835920987658 Doi: 10.1177/1758835920987658 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Riedl, JM; Posch, F; Horvath, L; Gantschnigg, A; Renneberg, F; Schwarzenbacher, E; Moik, F; Barth, DA; Rossmann, CH; Stotz, M; Schaberl-Moser, R; Pichler, M; Stöger, H; Greil, R; Djanani, A; Schlick, K; Gerger, A Gemcitabine/nab-Paclitaxel versus FOLFIRINOX for palliative first-line treatment of advanced pancreatic cancer: A propensity score analysis.
Eur J Cancer. 2021; 151: 3-13. Doi: 10.1016/j.ejca.2021.03.040 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Scheipl, S; Brcic, I; Moser, T; Fischerauer, S; Riedl, J; Bergovec, M; Smolle, M; Posch, F; Gerger, A; Pichler, M; Stoeger, H; Leithner, A; Heitzer, E; Liegl-Atzwanger, B; Szkandera, J Molecular profiling of soft-tissue sarcomas with FoundationOne^® Heme identifies potential targets for sarcoma therapy: a single-centre experience.
Ther Adv Med Oncol. 2021; 13:17588359211029125 Doi: 10.1177/17588359211029125 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Scheipner, L; Smolle, MA; Barth, D; Posch, F; Stotz, M; Pichler, M; StÖger, H; Gerger, A; Riedl, JM The AST/ALT Ratio Is an Independent Prognostic Marker for Disease-free Survival in Stage II and III Colorectal Carcinoma.
Anticancer Res. 2021; 41(1):429-436 Doi: 10.21873/anticanres.14792
Web of Science PubMed FullText FullText_MUG

 

** Smolle, MA; Herbsthofer, L; Goda, M; Granegger, B; Brcic, I; Bergovec, M; Scheipl, S; Prietl, B; El-Heliebi, A; Pichler, M; Gerger, A; Posch, F; Tomberger, M; López-García, P; Feichtinger, J; Baumgartner, C; Leithner, A; Liegl-Atzwanger, B; Szkandera, J Influence of tumor-infiltrating immune cells on local control rate, distant metastasis, and survival in patients with soft tissue sarcoma.
Oncoimmunology. 2021; 10(1):1896658-1896658 Doi: 10.1080/2162402X.2021.1896658 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Smolle, MA; Herbsthofer, L; Granegger, B; Goda, M; Brcic, I; Bergovec, M; Scheipl, S; Prietl, B; Pichler, M; Gerger, A; Rossmann, C; Riedl, J; Tomberger, M; López-García, P; El-Heliebi, A; Leithner, A; Liegl-Atzwanger, B; Szkandera, J T-regulatory cells predict clinical outcome in soft tissue sarcoma patients: a clinico-pathological study.
Br J Cancer. 2021; 125(5):717-724 Doi: 10.1038/s41416-021-01456-0 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Unseld, M; Belic, J; Pierer, K; Zhou, Q; Moser, T; Bauer, R; Piringer, G; Gerger, A; Siebenhüner, A; Speicher, M; Heitzer, E; Prager, GW A higher ctDNA fraction decreases survival in regorafenib-treated metastatic colorectal cancer patients. Results from the regorafenib's liquid biopsy translational biomarker phase II pilot study.
Int J Cancer. 2021; 148(6):1452-1461 Doi: 10.1002/ijc.33303 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Review

** Kaiser, M; Semeraro, MD; Herrmann, M; Absenger, G; Gerger, A; Renner, W Immune Aging and Immunotherapy in Cancer.
Int J Mol Sci. 2021; 22(13): 7016 Doi: 10.3390/ijms22137016 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Abstract (Journal)

** Koeberle, D; Hubner, G; Schroder, J; Kisro, J; Welslau, M; Burkle, D; von der Heyde, E; Gohler, T; Schmidt, B; Muller-Huesmann, H; Krammer-Steiner, B; Forstbauer, H; Fuxius, S; Schwaner, I; Losem, C; Hering-Schubert, C; Reichenbach, F; Arnold, D; Fritsch, R; Gerger, A; Hegewisch-Becker, S; Vogel, A; Wagner, AD; Winder, T; Prager, G; Stintzing, S Encorafenib and cetuximab in patients with metastatic, BRAF V600E-mutated, colorectal carcinoma: a multi-centric, multi-national, prospective, non-interventional study in Germany, Austria and Switzerland - BERING CRC
ONCOL RES TREAT. 2021; 44: 219-220.
Web of Science

 

** Stintzing, S; Hubner, G; Schroder, J; Kisro, J; Welslau, M; Burkle, D; Gohler, T; Schmidt, B; Muller-Huesmann, H; Krammer-Steiner, B; von der Heyde, E; Reichenbach, F; Arnold, D; Gerger, A; Hegewisch-Becker, S; Vogel, A; Winder, T; Prager, G Encorafenib and cetuximab in patients with metastatic, BRAF V600E-mutated, colorectal carcinoma: A multi-centric, multi-national, prospective, longitudinal, non-interventional study in Germany and Austria - BERING CRC
ANN ONCOL. 2021; 32: S116-S116. Doi: 10.1016/j.annonc.2021.05.113 [Poster]
Web of Science FullText FullText_MUG

 

** Terbuch, A; Absenger, G; Steinlechner, S; Jost, P; Wurm, R; Wohlkonig, C; Olschewski, H; Richtig, E; Koch, L; Winder, T; Woll, E; Gerger, A Autriche - AUsTrian Registry for Immune CHEckpoint inhibitors
ONCOL RES TREAT. 2021; 44: 229-229. [Poster]
Web of Science

 

2020

Full paper/article (Journal)

** Barth, DA; Brenner, C; Riedl, JM; Prinz, F; Klocker, EV; Schlick, K; Kornprat, P; Lackner, K; Stöger, H; Stotz, M; Gerger, A; Pichler, M External validation of the prognostic relevance of the advanced lung cancer inflammation index (ALI) in pancreatic cancer patients.
Cancer Med. 2020; 9(15):5473-5479 Doi: 10.1002/cam4.3233 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Bianconi, D; Herac, M; Posch, F; Schmeidl, M; Unseld, M; Kieler, M; Brettner, R; Mullauer, L; Riedl, J; Gerger, A; Scheithauer, W; Prager, G Microvascular density assessed by CD31 predicts clinical benefit upon bevacizumab treatment in metastatic colorectal cancer: results of the PassionATE study, a translational prospective Phase II study of capecitabine and irinotecan plus bevacizumab followed by capecitabine and oxaliplatin plus bevacizumab or the reverse sequence in patients in mCRC.
THER ADV MED ONCOL. 2020; 12: 1758835920928635 Doi: 10.1177/1758835920928635 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Klocker, EV; Barth, DA; Riedl, JM; Prinz, F; Szkandera, J; Schlick, K; Kornprat, P; Lackner, K; Lindenmann, J; Stöger, H; Stotz, M; Gerger, A; Pichler, M Decreased Activity of Circulating Butyrylcholinesterase in Blood Is an Independent Prognostic Marker in Pancreatic Cancer Patients.
Cancers (Basel). 2020; 12(5): Doi: 10.3390/cancers12051154 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Klöckl, MC; Kasparek, AK; Riedl, JM; Moik, F; Mollnar, S; Stotz, M; Szkandera, J; Terbuch, A; Gerger, A; Niedrist, T; Pichler, M; Bauernhofer, T; Schilcher, G; Zitta, S; Rosenkranz, AR; Friedl, C; Stöger, H; Posch, F Estimation versus measurement of the glomerular filtration rate for kidney function assessment in patients with cancer undergoing cisplatin-based chemotherapy.
Sci Rep. 2020; 10(1):11219 Doi: 10.1038/s41598-020-68010-5 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Perakis, SO; Weber, S; Zhou, Q; Graf, R; Hojas, S; Riedl, JM; Gerger, A; Dandachi, N; Balic, M; Hoefler, G; Schuuring, E; Groen, HJM; Geigl, JB; Heitzer, E; Speicher, MR Comparison of three commercial decision support platforms for matching of next-generation sequencing results with therapies in patients with cancer.
ESMO Open. 2020; 5(5):e000872 Doi: 10.1136/esmoopen-2020-000872 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Prager, G; Gerger, A; Hofler, G; Webersinke, G; Rumpold, H; Winder, T; Bartsch, R; Preusser, M; Eisterer, W Position statement of the Austrian Society for Hematology and Medical Oncology on the use of molecular diagnostics in solid tumors.
MEMO-MAG EUR MED ONC. 2020; Doi: 10.1007/s12254-020-00662-5
Web of Science FullText FullText_MUG

 

** Riedl, JM; Barth, DA; Brueckl, WM; Zeitler, G; Foris, V; Mollnar, S; Stotz, M; Rossmann, CH; Terbuch, A; Balic, M; Niedrist, T; Bertsch, T; Stoeger, H; Pichler, M; Olschewski, H; Absenger, G; Ficker, JH; Gerger, A; Posch, F C-Reactive Protein (CRP) Levels in Immune Checkpoint Inhibitor Response and Progression in Advanced Non-Small Cell Lung Cancer: A Bi-Center Study.
Cancers (Basel). 2020; 12(8): Doi: 10.3390/cancers12082319 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Riedl, JM; Posch, F; Prager, G; Eisterer, W; Oehler, L; Sliwa, T; Wilthoner, K; Petzer, A; Pichler, P; Hubmann, E; Winder, T; Burgstaller, S; Korger, M; Andel, J; Greil, R; Neumann, HJ; Pecherstorfer, M; Philipp-Abbrederis, K; Djanani, A; Gruenberger, B; Laengle, F; Wöll, E; Gerger, A The AST/ALT (De Ritis) ratio predicts clinical outcome in patients with pancreatic cancer treated with first-line nab-paclitaxel and gemcitabine: post hoc analysis of an Austrian multicenter, noninterventional study.
Ther Adv Med Oncol. 2020; 12: 1758835919900872-1758835919900872. Doi: 10.1177/1758835919900872 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Smolle, MA; Sande, MV; Callegaro, D; Wunder, J; Hayes, A; Leitner, L; Bergovec, M; Tunn, PU; van Praag, V; Fiocco, M; Panotopoulos, J; Willegger, M; Windhager, R; Dijkstra, SPD; van Houdt, WJ; Riedl, JM; Stotz, M; Gerger, A; Pichler, M; Stöger, H; Liegl-Atzwanger, B; Smolle, J; Andreou, D; Leithner, A; Gronchi, A; Haas, RL; Szkandera, J Individualizing Follow-Up Strategies in High-Grade Soft Tissue Sarcoma with Flexible Parametric Competing Risk Regression Models.
Cancers (Basel). 2019; 12(1): Doi: 10.3390/cancers12010047 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Stelzl, A; Aziz, F; Riedl, JM; Posch, F; Smolle, MA; Stojakovic, T; Terbuch, A; Pichler, M; Bergovec, M; Leithner, A; Liegl-Atzwanger, B; Stotz, M; Gerger, A; Sourij, H; Szkandera, J Diabetes mellitus is independently associated with adverse clinical outcome in soft tissue sarcoma patients.
Sci Rep. 2020; 10(1): 12438-12438. Doi: 10.1038/s41598-020-69237-y [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Stotz, M; Barth, DA; Riedl, JM; Asamer, E; Klocker, EV; Kornprat, P; Hutterer, GC; Prinz, F; Lackner, K; Stöger, H; Gerger, A; Pichler, M The Lipase/Amylase Ratio (LAR) in Peripheral Blood Might Represent a Novel Prognostic Marker in Patients with Surgically Resectable Pancreatic Cancer.
Cancers (Basel). 2020; 12(7): Doi: 10.3390/cancers12071798 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Zhou, Q; Perakis, SO; Ulz, P; Mohan, S; Riedl, JM; Talakic, E; Lax, S; Tötsch, M; Hoefler, G; Bauernhofer, T; Pichler, M; Gerger, A; Geigl, JB; Heitzer, E; Speicher, MR Cell-free DNA analysis reveals POLR1D-mediated resistance to bevacizumab in colorectal cancer.
Genome Med. 2020; 12(1):20 Doi: 10.1186/s13073-020-0719-6 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Editorial

** Gerger, A Molecular profiling-ready for clinical routine.
MEMO-MAG EUR MED ONC. 2020; 13(4): 365-366. Doi: 10.1007/s12254-020-00663-4 [OPEN ACCESS]
Web of Science FullText FullText_MUG

 

Correction

** Ulz, P; Perakis, S; Zhou, Q; Moser, T; Belic, J; Lazzeri, I; Wölfler, A; Zebisch, A; Gerger, A; Pristauz, G; Petru, E; White, B; Roberts, CES; John, JS; Schimek, MG; Geigl, JB; Bauernhofer, T; Sill, H; Bock, C; Heitzer, E; Speicher, MR Publisher Correction: Inference of transcription factor binding from cell-free DNA enables tumor subtype prediction and early detection.
Nat Commun. 2020; 11(1): 1965-1965. Doi: 10.1038/s41467-020-15799-4 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Abstract (Journal)

** Gerger, A; Eisterer, W; Fuxius, S; Bastian, S; Koeberle, D; Welslau, M; Akhoundova, D; Maas, C; Uhlig, J; Fenchel, K; Greil, R; von der Heyde, E; Agocs, R; Weide, R; Modest, DP; Fritsch, R Retrospective analysis of treatment pathways in patients with BRAF(V600E)-mutant metastatic colorectal carcinoma - MORSECRC.
ONCOL RES TREAT. Abstractband für die Virtuelle Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie. 2020; 43(SUPPL 4):131-131.-Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie; OCT 9-11, 2020; Basel, SWITZERLAND. [Onlinepräsentation]
Web of Science

 

** Gerger, A; Riedl, JM; Perakis, S; Pregartner, G; Scheipner, L; Posch, F; Groller, K; Kashofer, K; Jahn, SW; Bauernhofer, T; Pichler, M; Stoger, H; Berghold, A; Hofler, G; Speicher, M; Heitzer, E Profiling of circulating tumour DNA for treatment selection in patients with advanced and refractory carcinoma: A prospective, two-stage phase II individualized cancer treatment trial.
ANN ONCOL. 2020; 31: S1095-S1096.-ESMO Virtual Congress; SEP 19-OCT 18, 2020; ELECTR NETWORK. Doi: 10.1016/j.annonc.2020.08.1331 [Onlinepräsentation] [OPEN ACCESS]
Web of Science FullText FullText_MUG

 

** Perakis, SO; Weber, S; Graf, R; Zhou, Q; Riedl, JM; Dandachi, N; Balic, M; Gerger, A; Schuuring, E; Groen, HJ; Geigl, JB; Speicher, MR; Heitzer, E Identification of actionable targets in advanced cancer patients from circulating tumor DNA using clinical decision support platforms
CANCER RES. 2020; 80(16):-AACR Annual Meeting; JUN 22-24, 2020; ELECTR NETWORK. Doi: 10.1158/1538-7445.AM2020-1315 [Poster]
Web of Science FullText FullText_MUG

 

** Posch, F; Barth, D; Brueckl, WM; Zeitler, G; Foris, V; Mollnar, S; Stotz, M; Rossmann, CH; Terbuch, A; Balic, M; Niedrist, T; Bertsch, T; Stoger, H; Pichler, M; Olschewski, H; Absenger, G; Ficker, JH; Gerger, A; Riedl, JM C-reactive protein (CRP) levels in immune checkpoint inhibitor response and progression in advanced non-small cell lung cancer: A bi-center study.
ANN ONCOL. 2020; 31: S286-S286.-ESMO Virtual Congress; SEP 19-OCT 18, 2020; ELECTR NETWORK. Doi: 10.1016/j.annonc.2020.08.234 [Poster] [OPEN ACCESS]
Web of Science FullText FullText_MUG

 

** Riedl, J; Perakis, S; Pregartner, G; Scheipner, L; Posch, F; Groller, K; Kashofer, K; Jahn, SW; Bauernhofer, T; Pichler, M; Stoger, H; Berghold, A; Hofler, G; Speicher, M; Heitzer, E; Gerger, A Individualized cancer treatment based on molecular profiling of circulating tumor DNA in patients with advanced and refractory carcinoma: a prospective phase II trial.
ONCOL RES TREAT. 2020; 43(SUPPL 4):249-249.-DGHO Jahrestagung; 09.10. -11.10.2020; Basel (virtueller Kongress). [Oral Communication]
Web of Science

 

** Riedl, J; Posch, F; Horvath, L; Gantschnigg, A; Renneberg, F; Schwarzenbacher, E; Moik, F; Barth, D; Schaberl-Moser, R; Stotz, M; Pichler, M; Stoger, H; Greil, R; Djanani, A; Schlick, K; Gerger, A FOLFIRINOX versus Gemcitabine/nab-Paclitaxel as palliative first-line treatment of advanced pancreatic cancer: An Austrian observational Tri-Center comparative effectiveness analysis.
ONCOL RES TREAT. 2020; 43(SUPPL 4):215-215. [Poster]
Web of Science

 

** Riedl, JM; Posch, F; Gantschnigg, A; Horvath, L; Renneberg, F; Schwarzenbacher, E; Moik, F; Barth, D; Stotz, M; Schaberl-Moser, R; Pichler, M; Stoger, H; Greil, R; Djanani, A; Schlick, K; Gerger, A FOLFIRINOX versus Gemcitabine/nabPaclitaxel as First-line palliative Therapy in advanced Pancreatic Cancer: a Propensity-Score Analysis.
WIEN KLIN WOCHENSCHR. Abstracts 51. Jahrestagung der Österreichischen Gesellschaft für Innere Medizin. 2020; 132(SUPPL 2):78-79.-51. Jahrestagung der Österreichischen Gesellschaft für Innere Medizin; SEP 24-26, 2020; Salzburg, AUSTRIA. [Poster]
Web of Science

 

** Riedl, JM; Posch, F; Horvath, L; Gantschnigg, A; Renneberg, F; Schwarzenbacher, E; Moik, F; Barth, D; Stotz, M; Schaberl-Moser, R; Pichler, M; Stoger, H; Greil, R; Djanani, A; Schlick, K; Gerger, A Gemcitabine/nab-paclitaxel versus (modified) FOLFIRINOX for palliative first-line treatment of advanced pancreatic cancer: A propensity score analysis.
ANN ONCOL. 2020; 31: S942-S942.-ESMO Virtual Congress; SEP 19-OCT 18, 2020; ELECTR NETWORK. Doi: 10.1016/j.annonc.2020.08.2013 [Poster] [OPEN ACCESS]
Web of Science FullText FullText_MUG

 

** Schwarzenbacher, E; Moik, F; Horvath, L; Renneberg, F; Posch, F; Barth, D; Gantschnigg, A; Schaberl-Moser, R; Pichler, M; Stotz, M; Stoger, H; Ay, C; Greil, R; Gerger, A; Djanani, A; Schlick, K; Riedl, J Incidence, prediction and outcome of venous and arterial thromboembolism in patients with advanced pancreatic cancer treated with palliative first line chemotherapy of Gemcitabine/nab-Paclitxel or FOLFIRINOX.
ONCOL RES TREAT. 2020; 43(SUPPL 4):214-214. [Poster]
Web of Science

 

** Schwarzenbacher, E; Moik, F; Posch, F; Horvath, L; Gantschnigg, A; Renneberg, F; Barth, D; Stotz, M; Schaberl-Moser, R; Pichler, M; Ay, C; Stoger, H; Greil, R; Djanani, A; Gerger, A; Schlick, K; Riedl, JM Patterns of venous and arterial thromboembolism in patients with advanced pancreatic cancer treated with palliative first line chemotherapy of gemcitabine/nab-paclitxel or FOLFIRINOX.
ANN ONCOL. 2020; 31: S949-S950.-ESMO Virtual Congress; SEP 19-OCT 18, 2020; ELECTR NETWORK. Doi: 10.1016/j.annonc.2020.08.2035 [Poster] [OPEN ACCESS]
Web of Science FullText FullText_MUG

 

2019

Full paper/article (Journal)

** Barth, DA; Riedl, JM; Posch, F; Smolle, MA; Kasparek, AK; Niedrist, T; Szkandera, J; Stöger, H; Pichler, M; Stotz, M; Gerger, A Critical evaluation of platelet size as a prognostic biomarker in colorectal cancer across multiple treatment settings: a retrospective cohort study.
Clin Transl Oncol. 2019; 21(8):1034-1043 Doi: 10.1007/s12094-019-02037-7 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Lembeck, AL; Posch, F; Klocker, EV; Szkandera, J; Schlick, K; Stojakovic, T; Kornprat, P; Lackner, C; Gerger, A; Stoeger, H; Stotz, M; Pichler, M Large platelet size is associated with poor outcome in patients with metastatic pancreatic cancer.
Clin Chem Lab Med. 2019; 57(5):740-744 Doi: 10.1515/cclm-2018-0016
Web of Science PubMed FullText FullText_MUG

 

** Moik, F; Riedl, JM; Winder, T; Terbuch, A; Rossmann, CH; Szkandera, J; Bauernhofer, T; Kasparek, AK; Schaberl-Moser, R; Reicher, A; Prinz, F; Pichler, M; Stöger, H; Stotz, M; Gerger, A; Posch, F Benefit of second-line systemic chemotherapy for advanced biliary tract cancer: A propensity score analysis.
Sci Rep. 2019; 9(1):5548 Doi: 10.1038/s41598-019-42069-1 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Smolle, MA; van Praag, VM; Posch, F; Bergovec, M; Leitner, L; Friesenbichler, J; Heregger, R; Riedl, JM; Pichler, M; Gerger, A; Szkandera, J; Stöger, H; Smolle-Jüttner, FM; Liegl-Atzwanger, B; Fiocco, M; van de Sande, MA; Leithner, A Surgery for metachronous metastasis of soft tissue sarcoma - A magnitude of benefit analysis using propensity score methods.
Eur J Surg Oncol. 2019; 45(2):242-248 Doi: 10.1016/j.ejso.2018.06.019
Web of Science PubMed FullText FullText_MUG

 

** Terbuch, A; Posch, F; Bauernhofer, T; Pichler, M; Peinsith, H; Szkandera, J; Riedl, J; Hutterer, GC; Pummer, K; Partl, R; Kapp, KS; Stöger, H; Stotz, M; Gerger, A Age as a Predictor of Treatment Outcome in Metastatic Testicular Germ Cell Tumors.
Anticancer Res. 2019; 39(10):5589-5596 Doi: 10.21873/anticanres.13753
Web of Science PubMed FullText FullText_MUG

 

** Ulz, P; Perakis, S; Zhou, Q; Moser, T; Belic, J; Lazzeri, I; Wölfler, A; Zebisch, A; Gerger, A; Pristauz, G; Petru, E; White, B; Roberts, CES; John, JS; Schimek, MG; Geigl, JB; Bauernhofer, T; Sill, H; Bock, C; Heitzer, E; Speicher, MR Inference of transcription factor binding from cell-free DNA enables tumor subtype prediction and early detection.
Nat Commun. 2019; 10(1): 4666-4666. Doi: 10.1038/s41467-019-12714-4 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Review

** Riedl, JM; Stotz, M; Gerger, A Role of immune checkpoint inhibitors in gastrointestinal cancer treatment
MEMO-MAG EUR MED ONC. 2019; 12(1): 71-76. Doi: 10.1007/s12254-019-0470-0 [OPEN ACCESS]
Web of Science FullText FullText_MUG

 

** Smolle, MA; Kashofer, K; Riedl, JM; Stotz, M; Gerger, A Genetic Analysis Using a Gene Panel in 87 Caucasian Patients With Colorectal Cancer: Own Results and Review of Literature.
Anticancer Res. 2019; 39(2): 847-852. Doi: 10.21873/anticanres.13184
Web of Science PubMed FullText FullText_MUG

 

** Wöll, E; Eisterer, W; Gerger, A; Kühr, T; Prager, GW; Rumpold, H; Ulrich-Pur, H; Vogl, U; Winder, T; Weiss, L; Greil, R Treatment Algorithm for Patients With Gastric Adenocarcinoma: An Austrian Consensus on Systemic Therapy.
Anticancer Res. 2019; 39(9): 4589-4596. Doi: 10.21873/anticanres.13638 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Abstract (Journal)

** Aziz, F; Stelzl, A; Riedl, J; Smolle, M; Stojakovic, T; Posch, F; Terbuch, A; Pichler, M; Leithner, A; Stoger, H; Liegl-Atzwanger, B; Stotz, M; Gerger, A; Szkandera, J; Sourij, H Diabetes is a predictor for survival in soft tissue sarcoma patients
WIEN KLIN WOCHENSCHR. 2019; 131(SUPPL 5):S477-S477. [Poster]
Web of Science

 

** Aziz, F; Stelzl, A; Riedl, JM; Smolle, MA; Stojakovic, T; Posch, F; Terbuch, A; Pichler, M; Leithner, A; Stoger, H; Liegl-Atzwanger, B; Stotz, M; Gerger, A; Szkandera, J; Sourij, H Association of serum glucose levels with disease free survival in soft tissue sarcoma patients
DIABETOLOGIA. 2019; 62: S562-S563.-55th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD); SEP 16-20, 2019; Barcelona, SPAIN. [Poster]
Web of Science

 

** Barth, DA; Riedl, JM; Foris, V; Posch, F; Mollnar, S; Stotz, M; Pichler, M; Stoger, H; Absenger, G; Olschewski, H; Gerger, A External validation and longitudinal extension of the LIPI (lung immune prognostic index) for immunotherapy outcomes in advanced non-small cell lung cancer
ONCOL RES TREAT. 2019; 42: 108-108. [Poster]
Web of Science

 

** Perakis, SO; Ulz, P; Riedl, JM; Scheipner, L; Kashofer, K; Hoefler, G; Geigl, JB; Speicher, MR; Heitzer, E; Gerger, A Molecular-biological tumor profiling for drug treatment selection in patients with advanced and refractory carcinoma: A prospective, two-stage Phase II individualized cancer treatment study
CANCER RES. 2019; 79(13):-Annual Meeting of the American-Association-for-Cancer-Research (AACR); MAR 29-APR 03, 2019; Atlanta, GA. Doi: 10.1158/1538-7445.AM2019-CT130 [Poster]
Web of Science FullText FullText_MUG

 

** Riedl, J; Posch, F; Prager, G; Eisterer, W; Ohler, L; Thamer, S; Wilthoner, K; Petzer, A; Pichler, P; Hubmann, E; Winder, T; Burgstaller, S; Korger, M; Andel, J; Greil, R; Pecherstorfer, M; Philipp-Abbrederis, K; Djanani, A; Gruenberger, B; Langle, F; Woll, E; Gerger, A The AST/ALT (De Ritis) ratio predicts clinical outcome in pancreatic cancer patients treated with first-line nab-paclitaxel and gemcitabine: post-hoc analysis of an Austrian multicenter, non-interventional study
ANN ONCOL. 2019; 30: -European-Society-for-Medical-Oncology (ESMO) 21st World Congress on Gastrointestinal Cancer; JUL 03-06, 2019; Barcelona, SPAIN. Doi: 10.1093/annonc/mdz155.285 [Poster] [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Riedl, JM; Barth, D; Posch, F; Foris, V; Absenger, G; Mollnar, S; Pichler, M; Stotz, M; Stoger, H; Olschewski, H; Gerger, A Longitudinal C-reactive protein (CRP) trajectories predict immune checkpoint inhibitor response and progression in advanced non-small cell lung cancer
ONCOL RES TREAT. 2019; 42: 115-115. [Poster]
Web of Science

 

** Riedl, JM; Barth, DA; Foris, V; Posch, F; Mollnar, S; Stotz, M; Pichler, M; Stoger, H; Absenger, G; Olschewski, H; Gerger, A External validation and longitudinal extension of the LIPI (Lung Immune Prognostic Index) for immunotherapy outcomes in advanced non-small cell lung cancer
ANN ONCOL. 2019; 30: -44th Congress of the European-Society-for-Medical-Oncology (ESMO); SEP 27-OCT 01, 2019; Barcelona, SPAIN. [Poster]
Web of Science

 

2018

Full paper/article (Journal)

** Asamer, E; Szkandera, J; Gibiser, P; Lembeck, AL; Stojakovic, T; Kornprat, P; Lackner, C; Winder, T; Schlick, K; Stöger, H; Gerger, A; Pichler, M; Stotz, M Elevated amylase in plasma represents an adverse prognostic marker in patients with metastatic pancreatic cancer : A retrospective analysis.
Wien Klin Wochenschr. 2018; 130(19-20):569-574 Doi: 10.1007/s00508-018-1383-3 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Margonis, GA; Buettner, S; Andreatos, N; Kim, Y; Wagner, D; Sasaki, K; Beer, A; Schwarz, C; Løes, IM; Smolle, M; Kamphues, C; He, J; Pawlik, TM; Kaczirek, K; Poultsides, G; Lønning, PE; Cameron, JL; Burkhart, RA; Gerger, A; Aucejo, FN; Kreis, ME; Wolfgang, CL; Weiss, MJ Association of BRAF Mutations With Survival and Recurrence in Surgically Treated Patients With Metastatic Colorectal Liver Cancer.
JAMA Surg. 2018; 153(7): e180996-e180996. Doi: 10.1001/jamasurg.2018.0996 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Posch, F; Partl, R; Döller, C; Riedl, JM; Smolle, M; Leitner, L; Bergovec, M; Liegl-Atzwanger, B; Stotz, M; Bezan, A; Gerger, A; Pichler, M; Kapp, KS; Stöger, H; Leithner, A; Szkandera, J Benefit of Adjuvant Radiotherapy for Local Control, Distant Metastasis, and Survival Outcomes in Patients with Localized Soft Tissue Sarcoma: Comparative Effectiveness Analysis of an Observational Cohort Study.
Ann Surg Oncol. 2018; 25(3):776-783 Doi: 10.1245/s10434-017-6080-3 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Posch, F; Silina, K; Leibl, S; Mündlein, A; Moch, H; Siebenhüner, A; Samaras, P; Riedl, J; Stotz, M; Szkandera, J; Stöger, H; Pichler, M; Stupp, R; van den Broek, M; Schraml, P; Gerger, A; Petrausch, U; Winder, T Maturation of tertiary lymphoid structures and recurrence of stage II and III colorectal cancer.
Oncoimmunology. 2018; 7(2):e1378844-e1378844 Doi: 10.1080/2162402X.2017.1378844 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Terbuch, A; Adiprasito, JB; Stiegelbauer, V; Seles, M; Klec, C; Pichler, GP; Resel, M; Posch, F; Lembeck, AL; Stöger, H; Szkandera, J; Pummer, K; Bauernhofer, T; Hutterer, GC; Gerger, A; Stotz, M; Pichler, M MiR-371a-3p Serum Levels Are Increased in Recurrence of Testicular Germ Cell Tumor Patients.
Int J Mol Sci. 2018; 19(10): Doi: 10.3390/ijms19103130 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Terbuch, A; Posch, F; Partl, R; Zurl, B; Bauernhofer, T; Pichler, M; Szkandera, J; Hutterer, GC; Pummer, K; Kapp, KS; Stöger, H; Gerger, A; Stotz, M Risk stratification for febrile neutropenia in patients with testicular germ cell tumors.
Cancer Med. 2018; 7(2):508-514 Doi: 10.1002/cam4.1317 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Zöchmeister, C; Brezina, S; Hofer, P; Baierl, A; Bergmann, MM; Bachleitner-Hofmann, T; Karner-Hanusch, J; Stift, A; Gerger, A; Leeb, G; Mach, K; Rachakonda, S; Kumar, R; Gsur, A Leukocyte telomere length throughout the continuum of colorectal carcinogenesis.
Oncotarget. 2018; 9(17): 13582-13592. Doi: 10.18632/oncotarget.24431 [OPEN ACCESS]
PubMed FullText FullText_MUG

 

Abstract (Journal)

** Andritsch, E; Farkas, C; Zloklikovits, S; Gerger, A; Stoger, H Meaning of personalized medicine and targeted medical therapies for patients with cancer in the context of expectations and hope
ONCOL RES TREAT. 2018; 41: 34-34. [Oral Communication]
Web of Science

 

** Eisterer, W; Gerger, A; Ohler, L; Mlineritsch, B; Sliwa, T; Wilthoner, K; Petzer, A; Pichler, P; Hubmann, E; Winder, T; Burgstaller, S; Korger, M; Andel, J; Woll, E; Neumann, H; Pecherstorfer, M; Philipp-Abbrederis, K; Djanani, A; Gruenberger, B; Langle, F; Prager, G Austrian real world data in elderly and younger metastatic pancreatic cancer patients: Interim results of a multicenter non-interventional study with nab-paclitaxel/gemcitabine
ANN ONCOL. . 2018; 29: -ESMO 20th World Congress on Gastrointestinal Cancer; JUN 20-23, 2018; Barcelona, SPAIN. [Poster]
Web of Science

 

** Leithner, A; van Praag, V; Posch, F; Bergovec, M; Leitner, L; Friesenbichler, J; Heregger, R; Smolle-Juttner, FM; Fiocco, M; van de Sande, M; Riedl, J; Pichler, M; Gerger, A; Szkandera, J; Stoger, H; Liegl-Atzwanger, B; Smolle, MA Efficacy of metastasectomy on survival in patients with metachronous soft tissue sarcoma-metastasis: Results of a bi-centre study including 135 patients
ANN ONCOL. Abstract Book of the 43rd ESMO Congress (ESMO 2018) 19–23 October 2018, Munich, Germany. 2018; 29(S8):-43rd ESMO Congress (ESMO); OCT 19-23, 2018; Munich, GERMANY. [Poster]
Web of Science

 

** Mollnar, S; Pondorfer, P; Reinisch, S; Moik, F; Halm, M; Kasparek, AK; Klockl, MC; Stotz, M; Szkandera, J; Gerger, A; Vasicek, S; Weiland, T; Pichler, M; Stoger, H; Thurnher, D; Posch, F Definitive chemoradiotherapy with or without induction chemotherapy for unresectable squamous cell carcinoma of the head & neck: a propensity-score analysis
ONCOL RES TREAT. 2018; 41: 248-248. [Poster]
Web of Science

 

** Prager, G; Gerger, A; Eisterer, W; Mlineritsch, B; Sliwa, T; Wilthoner, K; Petzer, A; Pichler, P; Hubman, E; Winder, T; Burgstaller, S; Korger, M; Andel, J; Woll, E; Neumann, H; Pecherstorfer, M; Philipp-Abbrederis, K; Djanani, A; Grunberger, B; Ohler, L Subgroup analysis in elderly patients with metastatic pancreatic cancer: Preliminary results of Austrian real world data with nab-paclitaxel/gemcitabine
ONCOL RES TREAT. 2018; 41: 125-126. [Oral Communication]
Web of Science

 

Abstract (Proceedings)

** Klöckl, MC; Kasparek, AK; Riedl, J; Moik ,F; Mollnar, S; Stotz, M; Szkandera, J; Terbuch, A; Gerger, A; Niedrist, T; Pichler, M; Bauernhofer T; Stöger H; Posch, F Estimated versus measured glomerular filtration rate to evaluate kidney function in patients with cancer undergoing cisplatin-based chemotherapy
Oncology Research and Treatment . 2018; 41(Suppl4):224-224.-Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie; SEP 28- OCT 2, 2018; Vienna, AUSTRIA. (ISBN: 978-3-318-06425-4 ) [Poster]
Web of Science FullText

 

2017

Full paper/article (Journal)

** Bezan, A; Posch, F; Ploner, F; Bauernhofer, T; Pichler, M; Szkandera, J; Hutterer, GC; Pummer, K; Gary, T; Samonigg, H; Beyer, J; Winder, T; Hermanns, T; Fankhauser, CD; Gerger, A; Stotz, M Risk stratification for venous thromboembolism in patients with testicular germ cell tumors.
PLoS One. 2017; 12(4):e0176283-e0176283 Doi: 10.1371/journal.pone.0176283 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Dediu, M; Gerger, A; Zojer, N; Bartsch, R My personal highlights of ESMO 2016.
Memo. 2017; 10(1):46-47 Doi: 10.1007/s12254-017-0314-8 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Hofer, P; Hagmann, M; Brezina, S; Dolejsi, E; Mach, K; Leeb, G; Baierl, A; Buch, S; Sutterlüty-Fall, H; Karner-Hanusch, J; Bergmann, MM; Bachleitner-Hofmann, T; Stift, A; Gerger, A; Rötzer, K; Karner, J; Stättner, S; Waldenberger, M; Meitinger, T; Strauch, K; Linseisen, J; Gieger, C; Frommlet, F; Gsur, A Bayesian and frequentist analysis of an Austrian genome-wide association study of colorectal cancer and advanced adenomas.
Oncotarget. 2017; 8(58):98623-98634 Doi: 10.18632/oncotarget.21697 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Nadal, C; Winder, T; Gerger, A; Tougeron, D Future perspectives of circulating tumor DNA in colorectal cancer.
Tumour Biol. 2017; 39(5):1010428317705749-1010428317705749 Doi: 10.1177/1010428317705749 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Pichler, M; Stiegelbauer, V; Vychytilova-Faltejskova, P; Ivan, C; Ling, H; Winter, E; Zhang, X; Goblirsch, M; Wulf-Goldenberg, A; Ohtsuka, M; Haybaeck, J; Svoboda, M; Okugawa, Y; Gerger, A; Hoefler, G; Goel, A; Slaby, O; Calin, GA Genome-Wide miRNA Analysis Identifies miR-188-3p as a Novel Prognostic Marker and Molecular Factor Involved in Colorectal Carcinogenesis.
Clin Cancer Res. 2017; 23(5):1323-1333 Doi: 10.1158/1078-0432.CCR-16-0497 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Posch, F; Leitner, L; Bergovec, M; Bezan, A; Stotz, M; Gerger, A; Pichler, M; Stöger, H; Liegl-Atzwanger, B; Leithner, A; Szkandera, J Can Multistate Modeling of Local Recurrence, Distant Metastasis, and Death Improve the Prediction of Outcome in Patients With Soft Tissue Sarcomas?
Clin Orthop Relat Res. 2017; 475(5):1427-1435 Doi: 10.1007/s11999-017-5232-x [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Richtig, G; Aigelsreiter, A; Schwarzenbacher, D; Ress, AL; Adiprasito, JB; Stiegelbauer, V; Hoefler, G; Schauer, S; Kiesslich, T; Kornprat, P; Winder, T; Eisner, F; Gerger, A; Stoeger, H; Stauber, R; Lackner, C; Pichler, M SOX9 is a proliferation and stem cell factor in hepatocellular carcinoma and possess widespread prognostic significance in different cancer types.
PLoS One. 2017; 12(11):e0187814-e0187814 Doi: 10.1371/journal.pone.0187814 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Riedl, JM; Posch, F; Bezan, A; Szkandera, J; Smolle, MA; Winder, T; Rossmann, CH; Schaberl-Moser, R; Pichler, M; Stotz, M; Stöger, H; Gerger, A Patterns of venous thromboembolism risk in patients with localized colorectal cancer undergoing adjuvant chemotherapy or active surveillance: an observational cohort study.
BMC Cancer. 2017; 17(1):415-415 Doi: 10.1186/s12885-017-3392-4 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Riedl, JM; Posch, F; Moik, F; Bezan, A; Szkandera, J; Smolle, MA; Kasparek, AK; Pichler, M; Stöger, H; Stotz, M; Gerger, A Inflammatory biomarkers in metastatic colorectal cancer: prognostic and predictive role beyond the first line setting.
Oncotarget. 2017; 8(56):96048-96061 Doi: 10.18632/oncotarget.21647 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Seeber, A; Gastl, G; Eisterer, W; Gampenrieder, SP; Gerger, A; Kieler, M; Pichler, M; Prager, GW; Untergasser, G; Weltermann, A; Greil, R The first meeting of the Austrian Expert Panel for Molecular Cancer Profiling
MEMO-MAG EUR MED ONC. 2017; 10(4): 255-258. Doi: 10.1007/s12254-017-0369-6
Web of Science FullText FullText_MUG

 

** Stiegelbauer, V; Vychytilova-Faltejskova, P; Karbiener, M; Pehserl, AM; Reicher, A; Resel, M; Heitzer, E; Ivan, C; Bullock, M; Ling, H; Deutsch, A; Wulf-Goldenberg, A; Adiprasito, JB; Stoeger, H; Haybaeck, J; Svoboda, M; Stotz, M; Hoefler, G; Slaby, O; Calin, GA; Gerger, A; Pichler, M miR-196b-5p Regulates Colorectal Cancer Cell Migration and Metastases through Interaction with HOXB7 and GALNT5.
Clin Cancer Res. 2017; 23(17):5255-5266 Doi: 10.1158/1078-0432.CCR-17-0023 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Stotz, M; Herzog, SA; Pichler, M; Smolle, M; Riedl, J; Rossmann, C; Bezan, A; Stöger, H; Renner, W; Berghold, A; Gerger, A Cancer Stem Cell Gene Variants in CD44 Predict Outcome in Stage II and Stage III Colon Cancer Patients.
Anticancer Res. 2017; 37(4):2011-2018 Doi: 10.21873/anticanres.11545 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Terbuch, A; Posch, F; Annerer, LM; Bauernhofer, T; Pichler, M; Szkandera, J; Hutterer, GC; Pummer, K; Partl, R; Kapp, KS; Stöger, H; Gerger, A; Stotz, M Long-term cardiovascular complications in stage I seminoma patients.
Clin Transl Oncol. 2017; 19(11):1400-1408 Doi: 10.1007/s12094-017-1742-y [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Review

** Goblirsch, M; Richtig, G; Slaby, O; Berindan-Neagoe, I; Gerger, A; Pichler, M MicroRNAs as a tool to aid stratification of colorectal cancer patients and to guide therapy.
Pharmacogenomics. 2017; 18(10):1027-1038 Doi: 10.2217/pgs-2017-0004
Web of Science PubMed FullText FullText_MUG

 

Abstract (Journal)

** Bezan, A; Pasch, F; Bauernhofer, T; Pichler, M; Szkandera, J; Hutterer, GC; Pummer, K; Partl, R; Zurl, B; Kapp, K; Stager, H; Gerger, A; Stotz, M Clinical characterization of febrile neutropenia episodes in patients with testicular germ cell tumors.
J CLIN ONCOL. 2017; 35: -53rd Annual Clinical Science Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Symposium on Old Targets, New Drugs - Her2 and MET; JUN 02-07, 2017; Chicago, IL. Doi: 10.1200/JCO.2017.35.15_suppl.e16038 [Oral Communication]
Web of Science FullText FullText_MUG

 

** Gerger, A Potential role of ctDNA in therapy management
ONCOL RES TREAT. 2017; 40: 193-193. [Oral Communication]
Web of Science

 

2016

Full paper/article (Journal)

** Kainhofer, V; Smolle, MA; Szkandera, J; Liegl-Atzwanger, B; Maurer-Ertl, W; Gerger, A; Riedl, J; Leithner, A The width of resection margins influences local recurrence in soft tissue sarcoma patients.
Eur J Surg Oncol. 2016; 42(6):899-906 Doi: 10.1016/j.ejso.2016.03.026
Web of Science PubMed FullText FullText_MUG

 

** Krenn-Pilko, S; Langsenlehner, U; Stojakovic, T; Pichler, M; Gerger, A; Kapp, KS; Langsenlehner, T The elevated preoperative derived neutrophil-to-lymphocyte ratio predicts poor clinical outcome in breast cancer patients.
Tumour Biol. 2016; 37(1):361-368 Doi: 10.1007/s13277-015-3805-4 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Pehserl, AM; Ress, AL; Stanzer, S; Resel, M; Karbiener, M; Stadelmeyer, E; Stiegelbauer, V; Gerger, A; Mayr, C; Scheideler, M; Hutterer, GC; Bauernhofer, T; Kiesslich, T; Pichler, M Comprehensive Analysis of miRNome Alterations in Response to Sorafenib Treatment in Colorectal Cancer Cells.
Int J Mol Sci. 2016; 17(12): Doi: 10.3390/ijms17122011 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Rief, P; Pichler, M; Raggam, R; Hafner, F; Gerger, A; Eller, P; Brodmann, M; Gary, T The AST/ALT (De-Ritis) ratio: A novel marker for critical limb ischemia in peripheral arterial occlusive disease patients.
Medicine (Baltimore). 2016; 95(24):e3843-e3843 Doi: 10.1097/MD.0000000000003843 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Stotz, M; Liegl-Atzwanger, B; Posch, F; Mrsic, E; Thalhammer, M; Stojakovic, T; Bezan, A; Pichler, M; Gerger, A; Szkandera, J Blood-Based Biomarkers Are Associated with Disease Recurrence and Survival in Gastrointestinal Stroma Tumor Patients after Surgical Resection.
PLoS One. 2016; 11(7):e0159448-e0159448 Doi: 10.1371/journal.pone.0159448 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Trummer, O; Langsenlehner, U; Krenn-Pilko, S; Pieber, TR; Obermayer-Pietsch, B; Gerger, A; Renner, W; Langsenlehner, T Vitamin D and prostate cancer prognosis: a Mendelian randomization study.
World J Urol. 2016; 34(4):607-611 Doi: 10.1007/s00345-015-1646-9 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Ulz, P; Gerger, A; Belic, J; Heitzer, E Potentials, challenges and limitations of a molecular characterization of circulating tumor DNA for the management of cancer patients
LABORATORIUMSMEDIZIN. 2016; 40(5): 323-334. Doi: 10.1515/labmed-2016-0049 [OPEN ACCESS]
Web of Science FullText FullText_MUG

 

** Wibmer, C; Amrein, K; Fahrleitner-Pammer, A; Gilg, MM; Berghold, A; Hutterer, GC; Maurer-Ertl, W; Gerger, A; Leithner, A; Pichler, M; Szkandera, J Serum sclerostin levels in renal cell carcinoma patients with bone metastases.
Sci Rep. 2016; 6(4):33551-33551 Doi: 10.1038/srep33551 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Review

** Cerk, S; Schwarzenbacher, D; Adiprasito, JB; Stotz, M; Hutterer, GC; Gerger, A; Ling, H; Calin, GA; Pichler, M Current Status of Long Non-Coding RNAs in Human Breast Cancer.
Int J Mol Sci. 2016; 17(9): Doi: 10.3390/ijms17091485 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Seles, M; Hutterer, GC; Kiesslich, T; Pummer, K; Berindan-Neagoe, I; Perakis, S; Schwarzenbacher, D; Stotz, M; Gerger, A; Pichler, M Current Insights into Long Non-Coding RNAs in Renal Cell Carcinoma.
Int J Mol Sci. 2016; 17(4):573-573 Doi: 10.3390/ijms17040573 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Speicher, MR; Gerger, A; Hoefler, G Liquid biopsies. A multidisciplinary challenge for human geneticists, oncologists, and pathologists
MED GENET-BERLIN. 2016; 28(2): 245-250. Doi: 10.1007/s11825-016-0090-6 [OPEN ACCESS]
Web of Science FullText FullText_MUG

 

Abstract (Journal)

** Riedl, J; Posch, F; Stotz, M; Bezan, A; Winder, T; Schaberl-Moser, R; Pichler, M; Stoeger, H; Gerger, A Patterns of venous thromboembolism risk in patients with localized colorectal cancer undergoing adjuvant chemotherapy or active surveillance
ANN ONCOL. 2016; 27: -41st Congress of the European-Society-for-Medical-Oncology (ESMO); OCT 07-11, 2016; Copenhagen, DENMARK. Doi: 10.1093/annonc/mdw370.107 [Poster]
Web of Science FullText FullText_MUG

 

** Scheithauer, W; Prager, G; Greil, R; Mlineritsch, B; Schaberl-Moser, R; Gerger, A; Langle, F; Viragos-Toth, I; Andel, J; Pichler, A; Pecherstorfer, M; Kretschmer, A; Seebacher, A; Jagdt, B; Eisterer, W; Krippl, P Secondary resectability rates observed in a multicenter randomized phase II study of modified capecitabine/ irinotecan (mXELIRI) plus bevacizumab (bev) followed by capecitabine/oxaliplatin (XELOX) plus bev or the reverse sequence in patients with metastatic colorectal cancer (mCRC)
ANN ONCOL. 2016; 27: -41st Congress of the European-Society-for-Medical-Oncology (ESMO); OCT 07-11, 2016; Copenhagen, DENMARK. Doi: 10.1093/annonc/mdw370.41 [Poster]
Web of Science FullText FullText_MUG

 

** Silina, K; Petrausch, U; Posch, F; Leibl, S; Mundlein, A; Moch, H; Siebenhuner, A; Stupp, R; Riedl, J; Pestalozzi, BC; Schraml, P; Gerger, A; Winder, T Comprehensive molecular and immunological analysis to assess the tumor immune contexture in stage II and III colorectal cancer
ANN ONCOL. 2016; 27: Doi: 10.1093/annonc/mdw393.12
Web of Science FullText FullText_MUG

 

** Smolle, MA; Flick, H; Pichler, M; Olschewski, H; Lindenmann, J; Gerger, A Is it safe to use NSAIDs for pain control during chemical pleurodesis for malignant pleural effusion?
WIEN KLIN WOCHENSCHR. .. 2016; 128(19-20):772-773. [Poster]
Web of Science

 

** Smolle, MA; Flick, H; Pichler, M; Olschewski, H; Lindenmann, J; Gerger, A LATE-BREAKING ABSTRACT: Impact of NSAIDs on success of chemical pleurodesis in malignant pleural effusion
EUR RESPIR J. 2016; 48: Doi: 10.1183/13993003.congress-2016.PA3399
Web of Science FullText FullText_MUG

 

** Winder, T; Posch, F; Asamer, E; Stotz, M; Siebenhuner, A; Schlick, K; Magnes, T; Samaras, P; Szkandera, J; Clavien, PA; Neureiter, D; Greil, R; Pestalozzi, BC; Stoeger, H; Gerger, A; Egle, A; Pichler, M An elevated fibrinogen/CRP ratio predicts a remarkable survival advantage in patients with metastatic pancreatic cancer
ANN ONCOL. 2016; 27: -41st Congress of the European-Society-for-Medical-Oncology (ESMO); OCT 07-11, 2016; Copenhagen, DENMARK. Doi: 10.1093/annonc/mdw371.77 [Poster]
Web of Science FullText FullText_MUG

 

2015

Full paper/article (Journal)

** Benhaim, L; Zhang, W; Wakatsuki, T; Yang, D; Gerger, A; Bohanes, P; Paez, D; Loupakis, F; LaBonte, MJ; Ning, Y; El-Khoueiry, R; Ladner, R; Wilson, P; Zhang, H; Giamas, G; Stebbing, J; Lenz, HJ Genetic variants of kinase suppressors of Ras (KSR1) to predict survival in patients with ERα-positive advanced breast cancer.
Pharmacogenomics J. 2015; 15(3):235-240 Doi: 10.1038/tpj.2014.58
Web of Science PubMed FullText FullText_MUG

 

** Bohanes, P; Yang, D; Loupakis, F; LaBonte, MJ; Gerger, A; Ning, Y; Lenz, C; Lenz, F; Wakatsuki, T; Zhang, W; Benhaim, L; El-Khoueiry, A; El-Khoueiry, R; Lenz, HJ Integrin genetic variants and stage-specific tumor recurrence in patients with stage II and III colon cancer.
Pharmacogenomics J. 2015; 15(3):226-234 Doi: 10.1038/tpj.2014.66
Web of Science PubMed FullText FullText_MUG

 

** Krenn-Pilko, S; Langsenlehner, U; Stojakovic, T; Pichler, M; Gerger, A; Kapp, KS; Langsenlehner, T An elevated preoperative plasma fibrinogen level is associated with poor disease-specific and overall survival in breast cancer patients.
Breast. 2015; 24(5):667-672 Doi: 10.1016/j.breast.2015.08.003 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Langsenlehner, T; Pichler, M; Thurner, EM; Krenn-Pilko, S; Stojakovic, T; Gerger, A; Langsenlehner, U Evaluation of the platelet-to-lymphocyte ratio as a prognostic indicator in a European cohort of patients with prostate cancer treated with radiotherapy.
Urol Oncol. 2015; 33(5): 201.e9-201201. Doi: 10.1016/j.urolonc.2015.02.002
PubMed FullText FullText_MUG

 

** Langsenlehner, T; Thurner, EM; Krenn-Pilko, S; Langsenlehner, U; Stojakovic, T; Gerger, A; Pichler, M Validation of the neutrophil-to-lymphocyte ratio as a prognostic factor in a cohort of European prostate cancer patients.
World J Urol. 2015; 33(11):1661-1667 Doi: 10.1007/s00345-015-1494-7
Web of Science PubMed FullText FullText_MUG

 

** Langsenlehner, U; Hofmann, G; Renner, W; Gerger, A; Krenn-Pilko, S; Thurner, EM; Krippl, P; Langsenlehner, T Association of vascular endothelial growth factor - A gene polymorphisms and haplotypes with breast cancer metastases.
Acta Oncol. 2015; 54(3): 368-376. Doi: 10.3109/0284186X.2014.948056 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Reitz, D; Gerger, A; Seidel, J; Kornprat, P; Samonigg, H; Stotz, M; Szkandera, J; Pichler, M Combination of tumour markers CEA and CA19-9 improves the prognostic prediction in patients with pancreatic cancer.
J Clin Pathol. 2015; 68(6):427-433 Doi: 10.1136/jclinpath-2014-202451
Web of Science PubMed FullText FullText_MUG

 

** Ress, AL; Stiegelbauer, V; Winter, E; Schwarzenbacher, D; Kiesslich, T; Lax, S; Jahn, S; Deutsch, A; Bauernhofer, T; Ling, H; Samonigg, H; Gerger, A; Hoefler, G; Pichler, M MiR-96-5p influences cellular growth and is associated with poor survival in colorectal cancer patients.
Mol Carcinog. 2015; 54(11):1442-1450 Doi: 10.1002/mc.22218
Web of Science PubMed FullText FullText_MUG

 

** Schwarzenbacher, D; Stiegelbauer, V; Deutsch, A; Ress, AL; Aigelsreiter, A; Schauer, S; Wagner, K; Langsenlehner, T; Resel, M; Gerger, A; Ling, H; Ivan, C; Calin, GA; Hoefler, G; Rinner, B; Pichler, M Low spinophilin expression enhances aggressive biological behavior of breast cancer.
Oncotarget. 2015; 6(13):11191-11202 Doi: 10.18632/oncotarget.3586 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Sebio, A; Gerger, A; Matsusaka, S; Yang, D; Zhang, W; Stremitzer, S; Stintzing, S; Sunakawa, Y; Yamauchi, S; Ning, Y; Fujimoto, Y; Ueno, M; Lenz, HJ Genetic variants within obesity-related genes are associated with tumor recurrence in patients with stages II/III colon cancer.
Pharmacogenet Genomics. 2015; 25(1):30-37 Doi: 10.1097/FPC.0000000000000101 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Stotz, M; Szkandera, J; Stojakovic, T; Seidel, J; Samonigg, H; Kornprat, P; Schaberl-Moser, R; Seggewies, F; Hoefler, G; Gerger, A; Pichler, M The lymphocyte to monocyte ratio in peripheral blood represents a novel prognostic marker in patients with pancreatic cancer.
Clin Chem Lab Med. 2015; 53(3):499-506 Doi: 10.1515/cclm-2014-0447
Web of Science PubMed FullText FullText_MUG

 

** Szkandera, J; Gerger, A; Liegl-Atzwanger, B; Stotz, M; Samonigg, H; Friesenbichler, J; Stojakovic, T; Leithner, A; Pichler, M The derived neutrophil/lymphocyte ratio predicts poor clinical outcome in soft tissue sarcoma patients.
Am J Surg. 2015; 210(1): 111-116. Doi: 10.1016/j.amjsurg.2014.10.021
Web of Science PubMed FullText FullText_MUG

 

** Szkandera, J; Gerger, A; Liegl-Atzwanger, B; Stotz, M; Samonigg, H; Ploner, F; Stojakovic, T; Gary, T; Leithner, A; Pichler, M Uric acid levels in blood are associated with clinical outcome in soft-tissue sarcoma patients.
Clin Chem Lab Med. 2015; 53(3):493-497 Doi: 10.1515/cclm-2014-0486
Web of Science PubMed FullText FullText_MUG

 

** Szkandera, J; Herzog, S; Pichler, M; Stiegelbauer, V; Stotz, M; Schaberl-Moser, R; Samonigg, H; Asslaber, M; Lax, S; Leitner, G; Renner, W; Lenz, HJ; Berghold, A; Gerger, A LGR5 rs17109924 is a predictive genetic biomarker for time to recurrence in patients with colon cancer treated with 5-fluorouracil-based adjuvant chemotherapy.
Pharmacogenomics J. 2015; 15(5):391-396 Doi: 10.1038/tpj.2015.2 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Thurner, EM; Krenn-Pilko, S; Langsenlehner, U; Stojakovic, T; Pichler, M; Gerger, A; Kapp, KS; Langsenlehner, T The association of an elevated plasma fibrinogen level with cancer-specific and overall survival in prostate cancer patients.
World J Urol. 2015; 33(10):1467-1473 Doi: 10.1007/s00345-014-1459-2
Web of Science PubMed FullText FullText_MUG

 

** Thurner, EM; Krenn-Pilko, S; Langsenlehner, U; Stojakovic, T; Pichler, M; Gerger, A; Kapp, KS; Langsenlehner, T The elevated C-reactive protein level is associated with poor prognosis in prostate cancer patients treated with radiotherapy.
Eur J Cancer. 2015; 51(5):610-619 Doi: 10.1016/j.ejca.2015.01.002
Web of Science PubMed FullText FullText_MUG

 

Review

** Smolle, MA; Pichler, M; Haybaeck, J; Gerger, A Genetic markers of recurrence in colorectal cancer.
Pharmacogenomics. 2015; 16(11):1315-1328 Doi: 10.2217/pgs.15.83
Web of Science PubMed FullText FullText_MUG

 

** Stotz, M; Gerger, A; Haybaeck, J; Kiesslich, T; Bullock, MD; Pichler, M Molecular Targeted Therapies in Hepatocellular Carcinoma: Past, Present and Future.
Anticancer Res. 2015; 35(11):5737-5744
Web of Science PubMed

 

Abstract (Journal)

** Benhaim, L; Zhang, W; Wakatsuki, T; Gerger, A; Yang, DY; Paez, D; Ning, Y; El-Khoueiry, RE; Loupakis, F; Bohanes, PO; Stintzing, S; Heinemann, V; Lenz, HJ Genetic variants of kinases suppressors of Ras (KSR) to predict tumor response to first-line cetuximab in patients with mCRC: Prospective analysis in the FIRE 3 trial
J CLIN ONCOL. 2015; 33(15):-Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO); MAY 29-JUN 02, 2015; Chicago, IL. Doi: 10.1200/jco.2015.33.15_suppl.3613 [Poster]
Web of Science FullText FullText_MUG

 

** Krenn-Pilko, S; Langsenlehner, U; Thurner, E; Stojakovic, T; Pichler, M; Gerger, A; Kapp, KS; Langsenlehner, T An elevated preoperative plasma fibrinogen level is related with poor prognosis in breast cancer.
BREAST. 2015; 24: S104-S104.-14th St.Gallen International Breast Cancer Conference; MAR 18-21, 2015; Vienna, AUSTRIA. Doi: 10.1016/S0960-9776(15)70261-4 [Poster]
Web of Science FullText FullText_MUG

 

** Schwarzenbacher, D; Stiegelbauer, V; Deutsch, A; Ress, AL; Aigelsreiter, A; Schauer, S; Gerger, A; Hofler, G; Rinner, B; Pichler, M Low spinophilin expression is associated with poor prognosis and cellular growth in human breast cancer
ANN ONCOL. IMPAKT Breast Cancer Conference. 2015; 26: -IMPAKT Breast Cancer Conference; MAY 07-09, 2015; Brussels, BELGIUM. Doi: 10.1093/annonc/mdv120.6 [Poster]
Web of Science FullText FullText_MUG

 

2014

Full paper/article (Journal)

** Absenger, G; Benhaim, L; Szkandera, J; Zhang, W; Yang, D; Labonte, MJ; Pichler, M; Stotz, M; Samonigg, H; Renner, W; Gerger, A; Lenz, HJ The cyclin D1 (CCND1) rs9344 G>A polymorphism predicts clinical outcome in colon cancer patients treated with adjuvant 5-FU-based chemotherapy.
Pharmacogenomics J. 2014; 14(2):130-134 Doi: 10.1038/tpj.2013.15
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Aigelsreiter, AM; Aigelsreiter, A; Wehrschuetz, M; Ress, AL; Koller, K; Salzwimmer, M; Gerger, A; Schauer, S; Bauernhofer, T; Pichler, M Loss of the putative tumor suppressor protein spinophilin is associated with poor prognosis in head and neck cancer.
Hum Pathol. 2014; 45(4):683-690 Doi: 10.1016/j.humpath.2013.11.014
Web of Science PubMed FullText FullText_MUG

 

** Benhaim, L; Gerger, A; Bohanes, P; Paez, D; Wakatsuki, T; Yang, D; Labonte, MJ; Ning, Y; El-Khoueiry, R; Loupakis, F; Zhang, W; Laurent-Puig, P; Lenz, HJ Gender-specific profiling in SCN1A polymorphisms and time-to-recurrence in patients with stage II/III colorectal cancer treated with adjuvant 5-fluoruracil chemotherapy.
Pharmacogenomics J. 2014; 14(2):135-141 Doi: 10.1038/tpj.2013.21
Web of Science PubMed FullText FullText_MUG

 

** Dalpiaz, O; Ehrlich, GC; Mannweiler, S; Hernández, JM; Gerger, A; Stojakovic, T; Pummer, K; Zigeuner, R; Pichler, M; Hutterer, GC Validation of pretreatment neutrophil-lymphocyte ratio as a prognostic factor in a European cohort of patients with upper tract urothelial carcinoma.
BJU Int. 2014; 114(3):334-339 Doi: 10.1111/bju.12441 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Gary, T; Pichler, M; Belaj, K; Eller, P; Hafner, F; Gerger, A; Brodmann, M Lymphocyte-to-monocyte ratio: a novel marker for critical limb ischemia in PAOD patients.
Int J Clin Pract. 2014; 68(12):1483-1487 Doi: 10.1111/ijcp.12495
Web of Science PubMed FullText FullText_MUG

 

** Krenn-Pilko, S; Langsenlehner, U; Thurner, EM; Stojakovic, T; Pichler, M; Gerger, A; Kapp, KS; Langsenlehner, T The elevated preoperative platelet-to-lymphocyte ratio predicts poor prognosis in breast cancer patients.
Br J Cancer. 2014; 110(10):2524-2530 Doi: 10.1038/bjc.2014.163 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Langsenlehner, T; Thurner, EM; Renner, W; Gerger, A; Kapp, KS; Langsenlehner, U Association of genetic variants in VEGF-A with clinical recurrence in prostate cancer patients treated with definitive radiotherapy.
Strahlenther Onkol. 2014; 190(4):364-369 Doi: 10.1007/s00066-013-0503-2
Web of Science PubMed FullText FullText_MUG

 

** Mohan, S; Heitzer, E; Ulz, P; Lafer, I; Lax, S; Auer, M; Pichler, M; Gerger, A; Eisner, F; Hoefler, G; Bauernhofer, T; Geigl, JB; Speicher, MR Changes in colorectal carcinoma genomes under anti-EGFR therapy identified by whole-genome plasma DNA sequencing.
PLoS Genet. 2014; 10(3):e1004271-e1004271 Doi: 10.1371/journal.pgen.1004271 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Ning, Y; Gerger, A; Zhang, W; Hanna, DL; Yang, D; Winder, T; Wakatsuki, T; Labonte, MJ; Stintzing, S; Volz, N; Sunakawa, Y; Stremitzer, S; El-Khoueiry, R; Lenz, HJ Plastin polymorphisms predict gender- and stage-specific colon cancer recurrence after adjuvant chemotherapy.
Mol Cancer Ther. 2014; 13(2):528-539 Doi: 10.1158/1535-7163.MCT-13-0646 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Páez, D; Gerger, A; Zhang, W; Yang, D; Labonte, MJ; Benhanim, L; Kahn, M; Lenz, F; Lenz, C; Ning, Y; Wakatsuki, T; Loupakis, F; Lenz, HJ Association of common gene variants in the WNT/β-catenin pathway with colon cancer recurrence.
Pharmacogenomics J. 2014; 14(2):142-150 Doi: 10.1038/tpj.2013.20
Web of Science PubMed FullText FullText_MUG

 

** Pichler, M; Ress, AL; Winter, E; Stiegelbauer, V; Karbiener, M; Schwarzenbacher, D; Scheideler, M; Ivan, C; Jahn, SW; Kiesslich, T; Gerger, A; Bauernhofer, T; Calin, GA; Hoefler, G MiR-200a regulates epithelial to mesenchymal transition-related gene expression and determines prognosis in colorectal cancer patients.
Br J Cancer. 2014; 110(6):1614-1621 Doi: 10.1038/bjc.2014.51 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Pichler, M; Winter, E; Ress, AL; Bauernhofer, T; Gerger, A; Kiesslich, T; Lax, S; Samonigg, H; Hoefler, G miR-181a is associated with poor clinical outcome in patients with colorectal cancer treated with EGFR inhibitor.
J Clin Pathol. 2014; 67(3):198-203 Doi: 10.1136/jclinpath-2013-201904
Web of Science PubMed FullText FullText_MUG

 

** Ress, AL; Stiegelbauer, V; Schwarzenbacher, D; Deutsch, A; Perakis, S; Ling, H; Ivan, C; Calin, GA; Rinner, B; Gerger, A; Pichler, M Spinophilin expression determines cellular growth, cancer stemness and 5-flourouracil resistance in colorectal cancer.
Oncotarget. 2014; 5(18):8492-8502 Doi: 10.18632/oncotarget.2329 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Schulz, E; Klampfl, P; Holzapfel, S; Janecke, AR; Ulz, P; Renner, W; Kashofer, K; Nojima, S; Leitner, A; Zebisch, A; Wölfler, A; Hofer, S; Gerger, A; Lax, S; Beham-Schmid, C; Steinke, V; Heitzer, E; Geigl, JB; Windpassinger, C; Hoefler, G; Speicher, MR; Boland, CR; Kumanogoh, A; Sill, H Germline variants in the SEMA4A gene predispose to familial colorectal cancer type X.
Nat Commun. 2014; 5(10):5191-5191 Doi: 10.1038/ncomms6191 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Stotz, M; Pichler, M; Absenger, G; Szkandera, J; Arminger, F; Schaberl-Moser, R; Samonigg, H; Stojakovic, T; Gerger, A The preoperative lymphocyte to monocyte ratio predicts clinical outcome in patients with stage III colon cancer.
Br J Cancer. 2014; 110(2):435-440 Doi: 10.1038/bjc.2013.785 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Stotz, M; Szkandera, J; Seidel, J; Stojakovic, T; Samonigg, H; Reitz, D; Gary, T; Kornprat, P; Schaberl-Moser, R; Hoefler, G; Gerger, A; Pichler, M Evaluation of uric acid as a prognostic blood-based marker in a large cohort of pancreatic cancer patients.
PLoS One. 2014; 9(8):e104730-e104730 Doi: 10.1371/journal.pone.0104730 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Sunakawa, Y; Wakatsuki, T; Yang, D; Zhang, W; Ning, Y; Stintzing, S; Stremitzer, S; Yamauchi, S; Sebio, A; El-khoueiry, R; Iqbal, S; Barzi, A; Gerger, A; Stotz, M; Azuma, M; Watanabe, M; Koizumi, W; Lenz, HJ Prognostic impact of the c-MET polymorphism on the clinical outcome in locoregional gastric cancer patients.
Pharmacogenet Genomics. 2014; 24(12):588-596 Doi: 10.1097/FPC.0000000000000091 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Szkandera, J; Gerger, A; Liegl-Atzwanger, B; Absenger, G; Stotz, M; Friesenbichler, J; Trajanoski, S; Stojakovic, T; Eberhard, K; Leithner, A; Pichler, M The lymphocyte/monocyte ratio predicts poor clinical outcome and improves the predictive accuracy in patients with soft tissue sarcomas.
Int J Cancer. 2014; 135(2):362-370 Doi: 10.1002/ijc.28677 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Szkandera, J; Gerger, A; Liegl-Atzwanger, B; Stotz, M; Samonigg, H; Ploner, F; Stojakovic, T; Leithner, A; Pichler, M Pre-treatment anemia is a poor prognostic factor in soft tissue sarcoma patients.
PLoS One. 2014; 9(9):e107297-e107297 Doi: 10.1371/journal.pone.0107297 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Szkandera, J; Pichler, M; Absenger, G; Stotz, M; Arminger, F; Weissmueller, M; Schaberl-Moser, R; Samonigg, H; Kornprat, P; Stojakovic, T; Avian, A; Gerger, A The elevated preoperative platelet to lymphocyte ratio predicts decreased time to recurrence in colon cancer patients.
Am J Surg. 2014; 208(2):210-214 Doi: 10.1016/j.amjsurg.2013.10.030
Web of Science PubMed FullText FullText_MUG

 

** Szkandera, J; Pichler, M; Absenger, G; Stotz, M; Weissmueller, M; Samonigg, H; Asslaber, M; Lax, S; Leitner, G; Winder, T; Renner, W; Gerger, A A functional germline variant in GLI1 implicates hedgehog signaling in clinical outcome of stage II and III colon carcinoma patients.
Clin Cancer Res. 2014; 20(6):1687-1697 Doi: 10.1158/1078-0432.CCR-13-1517 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Szkandera, J; Pichler, M; Liegl-Atzwanger, B; Absenger, G; Stotz, M; Ploner, F; Stojakovic, T; Samonigg, H; Eberhard, K; Leithner, A; Gerger, A The elevated pre-operative plasma fibrinogen level is an independent negative prognostic factor for cancer-specific, disease-free and overall survival in soft-tissue sarcoma patients.
J Surg Oncol. 2014; 109(2):139-144 Doi: 10.1002/jso.23458
Web of Science PubMed FullText FullText_MUG

 

** Szkandera, J; Stotz, M; Absenger, G; Stojakovic, T; Samonigg, H; Kornprat, P; Schaberl-Moser, R; Alzoughbi, W; Lackner, C; Ress, AL; Seggewies, FS; Gerger, A; Hoefler, G; Pichler, M Validation of C-reactive protein levels as a prognostic indicator for survival in a large cohort of pancreatic cancer patients.
Br J Cancer. 2014; 110(1):183-188 Doi: 10.1038/bjc.2013.701 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Thurner, EM; Krenn-Pilko, S; Langsenlehner, U; Renner, W; Gerger, A; Kapp, KS; Langsenlehner, T Association of genetic variants in apoptosis genes FAS and FASL with radiation-induced late toxicity after prostate cancer radiotherapy.
Strahlenther Onkol. 2014; 190(3):304-309 Doi: 10.1007/s00066-013-0485-0
Web of Science PubMed FullText FullText_MUG

 

** Troppan, K; Deutsch, A; Gerger, A; Stojakovic, T; Beham-Schmid, C; Wenzl, K; Neumeister, P; Pichler, M The derived neutrophil to lymphocyte ratio is an independent prognostic factor in patients with diffuse large B-cell lymphoma.
Br J Cancer. 2014; 110(2):369-374 Doi: 10.1038/bjc.2013.763 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Winder, T; Giamas, G; Wilson, PM; Zhang, W; Yang, D; Bohanes, P; Ning, Y; Gerger, A; Stebbing, J; Lenz, HJ Insulin-like growth factor receptor polymorphism defines clinical outcome in estrogen receptor-positive breast cancer patients treated with tamoxifen.
Pharmacogenomics J. 2014; 14(1):28-34 Doi: 10.1038/tpj.2013.8
Web of Science PubMed FullText FullText_MUG

 

Review

** Bezan, A; Gerger, A; Pichler, M MicroRNAs in testicular cancer: implications for pathogenesis, diagnosis, prognosis and therapy.
Anticancer Res. 2014; 34(6):2709-2713
Web of Science PubMed

 

** Smolle, M; Uranitsch, S; Gerger, A; Pichler, M; Haybaeck, J Current status of long non-coding RNAs in human cancer with specific focus on colorectal cancer.
Int J Mol Sci. 2014; 15(8):13993-14013 Doi: 10.3390/ijms150813993 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Stiegelbauer, V; Perakis, S; Deutsch, A; Ling, H; Gerger, A; Pichler, M MicroRNAs as novel predictive biomarkers and therapeutic targets in colorectal cancer.
World J Gastroenterol. 2014; 20(33):11727-11735 Doi: 10.3748/wjg.v20.i33.11727 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Abstract (Journal)

** Hutterer, GC; Stoeckigt, C; Stojakovic, T; Hernandez, JMM; Eberhard, K; Mannweiler, S; Gerger, A; Pummer, K; Pichler, M; Zigeuner, R High preoperative monocyte-lymphocyte ratio (MLR) as a prognostic factor in nonmetastatic clear cell renal cell carcinoma.
J CLIN ONCOL. 2014; 32(4): Doi: 10.1200/jco.2014.32.4_suppl.534 [Poster]
Web of Science FullText FullText_MUG

 

** Krenn-Pilko, S; Langsenlehner, U; Thurner, EM; Stojakovic, T; Pichler, M; Gerger, A; Kapp, KS; Langsenlehner, T The elevated preoperative platelet to lymphocyte ratio is an independent prognostic marker in breast cancer patients
EUR J CANCER. 2014; 50: S213-S213.-9th European Breast Cancer Conference (EBCC); MAR 19-21, 2014; Glasgow, SCOTLAND. [Poster]
Web of Science

 

** Krenn-Pilko, S; Langsenlehner, U; Thurner, EM; Stojakovic, T; Pichler, M; Gerger, A; Kapp, KS; Langsenlehner, T; Elevated plasma fibrinogen levels as an independent prognostic marker in breast cancer patients.
STRAHLENTHER ONKOL. 2014; 190: 26-26.-20th Annual Congress of the German-Society-for-Radiation-Oncology; JUL 03-06, 2014; Dusseldorf, GERMANY. [Oral Communication]
Web of Science

 

** Krenn-Pilko, S; Thurner, EM; Pichler, M; Gerger, A; Langsenlehner, U; Kapp, KS; Langsenlehner, T; The preoperative Platelet/Lymphocyte Ratio is a predictive Factor for the Prognosis of Female Breast Cancer Patients.
STRAHLENTHER ONKOL. 2014; 190(1):129-129.-30th OEGRO Annual Conference; SEP 20-21, 2013; Bregenz, AUSTRIA. [Poster]
Web of Science

 

** Krenn-Pilko, S; Thurner, EM; Pichler, M; Gerger, A; Langsenlehner, U; Kapp, KS; Langsenlehner, T; Effect of Pentoxifylline on the Expression of IL1 beta and NF-kappa B in the Oral Mucous Membrane (Mouse) during fractionated Irradiation.
STRAHLENTHER ONKOL. 2014; 190(1):129-129.-30th OEGRO Annual Conference; SEP 20-21, 2013; Bregenz, AUSTRIA. [Poster]
Web of Science

 

** Schulz, E; Klampfl, P; Holzapfel, S; Janecke, AR; Ulz, P; Renner, W; Kashofer, K; Najima, S; Leitner, A; Zebisch, A; Wölfler, A; Hofer, S; Gerger, A; Lax, S; Beham-Schmid, C; Steinke, V; Geigl, JB; Höfler, G; Speicher, MR; Boland, CR; Kumanogoh, A; Sill, H Germline variants in the semaphorin SEMA4A confer susceptibility to familial colorectal cancer type X
Oncol Res Treat. 2014; 37(S5):105-105.-Annual Meeting of the German, Austrian and Swiss Associations of Hematology and Medical Oncology; OCT 10-14, 2014; Hamburg, GERMANY. (ISBN: 978-3-318-02811-9 ) [Oral Communication]
Web of Science

 

** Thurner, EM; Krenn-Pilko, S; Gerger, A; Pichler, M; Kapp, KS; Langsenlehner, U; Langsenlehner, T The elevated C-reactive protein (CRP) level is a poor prognostic factor in prostate cancer patients
ONCOL RES TREAT. 2014; 37: 179-179.-Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie 2014.; OCT 10-14, 2014; Hamburg, GERMANY. [Oral Communication]
Web of Science

 

** Thurner, EM; Krenn-Pilko, S; Langsenlehner, U; Renner, W; Gerger, A; Kapp, KS; Langsenlehner, T; Relation between Polymorphisms in the Apoptotic Genes FAS and FASL and radiogenic Long-Terms-Effects in Prostate Cancer Patients.
STRAHLENTHER ONKOL. 2014; 190(1):127-127.-30th OEGRO Annual Conference; SEP 20-21, 2013; Bregenz, AUSTRIA. [Poster]
Web of Science

 

** Thurner, EM; Krenn-Pilko, S; Langsenlehner, U; Stojakovic, T; Pichler, M; Gerger, A; Kapp, K; Langsenlehner, T C-reactive Protein (CRP) as a prognostic Marker in non-metastatic Prostate Cancer Patients
STRAHLENTHER ONKOL. 2014; 190: 61-61.-20th Annual Congress of the German-Society-for-Radiation-Oncology; JUL 03-06, 2014; Dusseldorf, GERMANY. [Poster]
Web of Science

 

2013

Full paper/article (Journal)

** Absenger, G; Szkandera, J; Pichler, M; Stotz, M; Arminger, F; Weissmueller, M; Schaberl-Moser, R; Samonigg, H; Stojakovic, T; Gerger, A A derived neutrophil to lymphocyte ratio predicts clinical outcome in stage II and III colon cancer patients.
Br J Cancer. 2013; 109(2):395-400 Doi: 10.1038/bjc.2013.346 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Absenger, G; Szkandera, J; Stotz, M; Pichler, M; Winder, T; Langsenlehner, T; Langsenlehner, U; Samonigg, H; Renner, W; Gerger, A A common and functional gene variant in the vascular endothelial growth factor a predicts clinical outcome in early-stage breast cancer.
Mol Carcinog. 2013; 52 Suppl 1(9):E96-102 Doi: 10.1002/mc.22028
Web of Science PubMed FullText FullText_MUG

 

** Absenger, G; Szkandera, J; Stotz, M; Postlmayr, U; Pichler, M; Ress, AL; Schaberl-Moser, R; Loibner, H; Samonigg, H; Gerger, A Preoperative neutrophil-to-lymphocyte ratio predicts clinical outcome in patients with stage II and III colon cancer.
Anticancer Res. 2013; 33(10):4591-4594
Web of Science PubMed

 

** Eisner, F; Schaberl-Moser, R; Gerger, A; Samonigg, H; Pichler, M Successful use of sorafenib after bortezomib failure in metastatic follicular thyroid cancer - a case report.
Onkologie. 2013; 36(6):368-370 Doi: 10.1159/000351252 (- Case Report)
Web of Science PubMed FullText FullText_MUG

 

** Gary, T; Pichler, M; Belaj, K; Hafner, F; Gerger, A; Froehlich, H; Eller, P; Pilger, E; Brodmann, M Neutrophil-to-lymphocyte ratio and its association with critical limb ischemia in PAOD patients.
PLoS One. 2013; 8(2):e56745-e56745 Doi: 10.1371/journal.pone.0056745 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Gary, T; Pichler, M; Belaj, K; Hafner, F; Gerger, A; Froehlich, H; Eller, P; Rief, P; Hackl, G; Pilger, E; Brodmann, M Platelet-to-lymphocyte ratio: a novel marker for critical limb ischemia in peripheral arterial occlusive disease patients.
PLoS One. 2013; 8(7):e67688-e67688 Doi: 10.1371/journal.pone.0067688 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Pichler, M; Hutterer, GC; Stoeckigt, C; Chromecki, TF; Stojakovic, T; Golbeck, S; Eberhard, K; Gerger, A; Mannweiler, S; Pummer, K; Zigeuner, R Validation of the pre-treatment neutrophil-lymphocyte ratio as a prognostic factor in a large European cohort of renal cell carcinoma patients.
Br J Cancer. 2013; 108(4):901-907 Doi: 10.1038/bjc.2013.28 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Stotz, M; Eisner, F; Szkandera, J; Absenger, G; Kornprat, P; Lackner, C; Samonigg, H; Gerger, A; Pichler, M Clinico-pathological characteristics and clinical outcome of different histological types of pancreatic cancer in a large Middle European series.
J Clin Pathol. 2013; 66(9):753-757 Doi: 10.1136/jclinpath-2012-201394
Web of Science PubMed FullText FullText_MUG

 

** Stotz, M; Gerger, A; Eisner, F; Szkandera, J; Loibner, H; Ress, AL; Kornprat, P; AlZoughbi, W; Zoughbi, WA; Seggewies, FS; Lackner, C; Stojakovic, T; Samonigg, H; Hoefler, G; Pichler, M Increased neutrophil-lymphocyte ratio is a poor prognostic factor in patients with primary operable and inoperable pancreatic cancer.
Br J Cancer. 2013; 109(2):416-421 Doi: 10.1038/bjc.2013.332 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Szkandera, J; Absenger, G; Liegl-Atzwanger, B; Pichler, M; Stotz, M; Gerger, S; Zacherl, M; Renner, W; Haijun, M; Leithner, A; Gerger, A Common gene variants in RAD51, XRCC2 and XPD are not associated with clinical outcome in soft-tissue sarcoma patients.
Cancer Epidemiol. 2013; 37(6):1003-1009 Doi: 10.1016/j.canep.2013.10.003
Web of Science PubMed FullText FullText_MUG

 

** Szkandera, J; Absenger, G; Liegl-Atzwanger, B; Pichler, M; Stotz, M; Samonigg, H; Glehr, M; Zacherl, M; Stojakovic, T; Gerger, A; Leithner, A Elevated preoperative neutrophil/lymphocyte ratio is associated with poor prognosis in soft-tissue sarcoma patients.
Br J Cancer. 2013; 108(8):1677-1683 Doi: 10.1038/bjc.2013.135 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Szkandera, J; Absenger, G; Pichler, M; Stotz, M; Langsenlehner, T; Samonigg, H; Renner, W; Gerger, A Association of common gene variants in vitamin D modulating genes and colon cancer recurrence.
J Cancer Res Clin Oncol. 2013; 139(9):1457-1464 Doi: 10.1007/s00432-013-1461-x
Web of Science PubMed FullText FullText_MUG

 

** Szkandera, J; Gerger, A; Liegl-Atzwanger, B; Absenger, G; Stotz, M; Samonigg, H; Maurer-Ertl, W; Stojakovic, T; Ploner, F; Leithner, A; Pichler, M Validation of the prognostic relevance of plasma C-reactive protein levels in soft-tissue sarcoma patients.
Br J Cancer. 2013; 109(9):2316-2322 Doi: 10.1038/bjc.2013.595 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Szkandera, J; Stotz, M; Eisner, F; Absenger, G; Stojakovic, T; Samonigg, H; Kornprat, P; Schaberl-Moser, R; Alzoughbi, W; Ress, AL; Seggewies, FS; Gerger, A; Hoefler, G; Pichler, M External validation of the derived neutrophil to lymphocyte ratio as a prognostic marker on a large cohort of pancreatic cancer patients.
PLoS One. 2013; 8(11):e78225-e78225 Doi: 10.1371/journal.pone.0078225 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Szkandera, J; Winder, T; Stotz, M; Weissmueller, M; Langsenlehner, T; Pichler, M; Samonigg, H; Renner, W; Gerger, A; Absenger, G A common gene variant in PLS3 predicts colon cancer recurrence in women.
Tumour Biol. 2013; 34(4):2183-2188 Doi: 10.1007/s13277-013-0754-7
Web of Science PubMed FullText FullText_MUG

 

** Winder, T; Wilson, PM; Yang, D; Zhang, W; Ning, Y; Power, DG; Bohanes, P; Gerger, A; Tang, LH; Shah, M; Lenz, HJ An individual coding polymorphism and the haplotype of the SPARC gene predict gastric cancer recurrence.
Pharmacogenomics J. 2013; 13(4):342-348 Doi: 10.1038/tpj.2012.11 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Review

** Szkandera, J; Kiesslich, T; Haybaeck, J; Gerger, A; Pichler, M Hedgehog signaling pathway in ovarian cancer.
Int J Mol Sci. 2013; 14(1):1179-1196 Doi: 10.3390/ijms14011179 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Correction

** Stotz, M; Gerger, A; Eisner, F; Szkandera, J; Loibner, H; Ress, AL; Kornprat, P; Alzoughbi, W; Seggewies, FS; Lackner, C; Stojakovic, T; Samonigg, H; Hoefler, G; Pichler, M Increased neutrophil-lymphocyte ratio is a poor prognostic factor in patients with primary operable as well as inoperable pancreatic cancer.
Br J Cancer. 2013; 109(7): 2026-2026. Doi: 10.1038/bjc.2013.591 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Abstract (Journal)

** Krenn-Pilko, S; Thurner, EM; Renner, W; Gerger, A; Kapp, KS; Langsenlehner, U; Langsenlehner, T The Relationship between VEGF Gene polymorphisms and Haplotypes with the Development of Distant metastases in postmenopausal Breast cancer patients
STRAHLENTHER ONKOL. . 2013; 189(2):182-183.-29th Annual Meeting of the Austrian-Society-of-Radiation-Oncology-Radiobiology-and-Medical-Radiophysics (OGRO); SEP 28-29, 2012; Gnunden, AUSTRIA. [Poster]
Web of Science

 

** Langsenlehner, T; Thurner, EM; Krenn-Pilko, S; Ehammer-Rosenkranz, A; Renner, W; Gerger, A; Kapp, KS; Langsenlehner, U Association between VEGF-A gene variants and clinical outcome in prostate cancer patients treated with definitive radiotherapy
EUR J CANCER. 2013; 49: S689-S689.-17th ECCO / 38th ESMO / 32nd ESTRO European Cancer Congress on Reinforcing Multidisciplinarity; SEP 27-OCT 01, 2013; Amsterdam, NETHERLANDS. [Poster]
Web of Science

 

** Thurner, EM; Krenn-Pilko, S; Renner, W; Gerger, A; Langsenlehner, U; Kapp, KS; Langsenlehner, T Genetic variants in DNA repair genes and radiation-induced late toxicity in prostate cancer patients
EUR J CANCER. 2013; 49: S693-S693.-17th ECCO / 38th ESMO / 32nd ESTRO European Cancer Congress on Reinforcing Multidisciplinarity; SEP 27-OCT 01, 2013; Amsterdam, NETHERLANDS. [Poster]
Web of Science

 

Comment

** Szkandera, J; Pichler, M; Gerger, A; Leithner, A Reply: Comment on 'Elevated preoperative neutrophil/lymphocyte ratio is associated with poor prognosis in soft-tissue sarcoma patients'
Br J Cancer. 2013; 108(12):2627-2627 Doi: 10.1038/bjc.2013.276 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Szkandera, J; Pichler, M; Stotz, M; Gerger, A Reply: comment on 'A derived neutrophil to lymphocyte ratio predicts clinical outcome in stage II and III colon cancer patients'.
Br J Cancer. 2013; 109(12):3126-3127 Doi: 10.1038/bjc.2013.599 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2012

Full paper/article (Journal)

** Al-Ali, BM; Ress, AL; Gerger, A; Pichler, M MicroRNAs in Renal Cell Carcinoma: Implications for Pathogenesis, Diagnosis, Prognosis and Therapy.
Anticancer Res. 2012; 32(9):3727-3732
Web of Science PubMed

 

** Bohanes, P; Yang, D; Chhibar, RS; Labonte, MJ; Winder, T; Ning, Y; Gerger, A; Benhaim, L; Paez, D; Wakatsuki, T; Loupakis, F; El-Khoueiry, R; Zhang, W; Lenz, HJ Influence of Sex on the Survival of Patients With Esophageal Cancer.
J Clin Oncol. 2012; 30(18):2265-2272 Doi: 10.1200/JCO.2011.38.8751 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Labonte, MJ; Wilson, PM; Yang, D; Zhang, W; Ladner, RD; Ning, Y; Gerger, A; Bohanes, PO; Benhaim, L; El-Khoueiry, R; El-Khoueiry, A; Lenz, HJ The Cyclin D1 (CCND1) A870G polymorphism predicts clinical outcome to lapatinib and capecitabine in HER2-positive metastatic breast cancer.
Ann Oncol. 2012; 23(6):1455-1464 Doi: 10.1093/annonc/mdr445 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Ning, Y; Labonte, MJ; Zhang, W; Bohanes, PO; Gerger, A; Yang, D; Benhaim, L; Paez, D; Rosenberg, DO; Nagulapalli Venkata, KC; Louie, SG; Petasis, NA; Ladner, RD; Lenz, HJ The CXCR2 antagonist, SCH-527123, shows antitumor activity and sensitizes cells to oxaliplatin in preclinical colon cancer models.
Mol Cancer Ther. 2012; 11(6):1353-1364 Doi: 10.1158/1535-7163.MCT-11-0915 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Szkandera, J; Absenger, G; Dandachi, N; Regitnig, P; Lax, S; Stotz, M; Samonigg, H; Renner, W; Gerger, A Analysis of functional germline polymorphisms for prediction of response to anthracycline-based neoadjuvant chemotherapy in breast cancer.
Mol Genet Genomics. 2012; 287(9):755-764 Doi: 10.1007/s00438-012-0715-7
Web of Science PubMed FullText FullText_MUG

 

** Szkandera, J; Absenger, G; Stotz, M; Weissmueller, M; Winder, T; Langsenlehner, T; Samonigg, H; Renner, W; Schippinger, W; Gerger, A The Functional Polymorphism of Erythropoietin Gene rs1617640 G>T Is Not Associated with Susceptibility and Clinical Outcome of Early-stage Breast Cancer.
Anticancer Res. 2012; 32(8):3473-3478
Web of Science PubMed

 

Short report/Letter

** Langsenlehner, T; Thurner, EM; Krenn-Pilko, S; Gerger, A; Langsenlehner, U Genetic prediction of radiation-induced morbidity in prostate cancer patients.
Radiother Oncol. 2012; 105(3): 380-381. Doi: 10.1016/j.radonc.2012.07.009
Web of Science PubMed FullText FullText_MUG

 

Abstract (Journal)

** Absenger, G; Szkandera, J; Weissmuller, M; Postlmayr, U; Pichler, M; Loibner, H; Samonigg, HS; Gerger, A; The preoperative neutrophil to lymphocyte ratio predicts disease-free survival and overall survival in patients with stage II and III colon cancer.
ONKOLOGIE. ONKOLOGIE35: 55-56. BASEL: KARGER; [Poster]
Web of Science

 

** Hofmann, G; Langsenlehner, T; Moazedi-Fuerst, F; Gerger, A; Kielhauser, S; Absenger, G; Szkandera, J; Samonigg, H; Krippl, P; Renner, W; COMMON VEGF GENE POLYMORPHISMS ARE NOT ASSOCIATED WITH RELAPSE-FREE SURVIVAL IN COLORECTAL CANCER PATIENTS.
ANN ONCOL. 2012; 23: 86-87.-14th World Congress on Gastrointestinal Cancer of the European-Society-for-Medical-Oncology (ESMO); JUN 27-30, 2012; Barcelona, SPAIN. [Poster]
Web of Science

 

** Hofmann, G; Langsenlehner, T; Moazedi-Fuerst, F; Gerger, A; Kielhauser, S; Thurner, E-M; Absenger, G; Szkandera, J; Samonigg, H; Glehr, M; Krippl, P; Renner, W Genetic variants of UGT1A4 and their impact on relapse-free survival in Tamoxifen treated breast cancer patients.
Onkologie. 2012; 35(S 6):64-64.-Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie; OCT 19-23, 2012; Stuttgart, GERMANY. [Poster]
Web of Science

 

** Krenn-Pilko, S; Hofmann, G; Renner, W; Gerger, A; Thurner, EM; Kapp, KS; Langsenlehner, U; Langsenlehner, T The Role of VEGF Gene Polymorphisms in the Development of Distant Metastases in Postmenopausal Breast Cancer Patients
EUR J CANCER. .... 2012; 48(1):S184-S185.-8th European Breast Cancer Conference (EBCC); MAR 21-24, 2012; Vienna, AUSTRIA. [Poster]
Web of Science

 

** Krenn-Pilko, S; Thurner, EM; Absenger, G; Renner, W; Gerger, A; Kapp, KS; Langsenlehner, U; Langsenlehner, T; Association Between Variants in the VEGF Gene and Distant Metastases in Postmenopausal Breast Cancer Patients.
EUR J CANCER. EUROPEAN JOURNAL OF CANCER48: S271-S271. OXFORD: ELSEVIER SCI LTD; ( Presented at: 22nd Biennial Congress of the European-Association-for-Cancer-Research, Barcelona, SPAIN, JUL 07-10, 2012) Doi: 10.1016/S0959-8049(12)71726-4 [Poster]
Web of Science FullText FullText_MUG

 

** Krenn-Pilko, S; Thurner, EM; Renner, W; Absenger, G; Gerger, A; Kapp, KS; Langsenlehner, T; Langsenlehner, U The Development of Distant Metastases in Postmenopausal Woman with Breast Cancer in Association with VEGF Gene Polymorphisms
EUR J CANCER. 2012; 48: 63-63.-24th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics; NOV 06-09, 2012; Dublin, IRELAND. Doi: 10.1016/S0959-8049(12)72008-7 [Poster]
Web of Science FullText FullText_MUG

 

** Szkandera, J; Absenger, G; Dandachi, N; Regitnig, P; Lax, S; Stotz, M; Winder, T; Samonigg, H; Renner, W; Gerger, A Analysis of functional germline polymorphisms for prediction of response to anthracycline-based neoadjuvant chemotherapy in breast cancer
WIEN KLIN WOCHENSCHR. 2012; 124(15-16):575-575. [Poster]
Web of Science

 

** Szkandera, J; Absenger, G; Stotz, M; Weissmuller, M; Winder, T; Langsenlehner, T; Samonigg, H; Renner, W; Schippinger, W; Gerger, A The functional polymorphism of erythropoietin gene rs1617640 G > T is not associated with susceptibility and clinical outcome of early-stage breast cancer
WIEN KLIN WOCHENSCHR. 2012; 124(15-16):575-575. [Poster]
Web of Science

 

** Szkandera, J; Winder, T; Absenger, G; Stotz, M; Weissmuller, M; Langsenlehner, T; Hofmann, G; Samonigg, H; Renner, W; Gerger, A; A COMMON GENE VARIANT IN PLS3 PREDICTS COLON CANCER RECURRENCE IN WOMEN.
ANN ONCOL. 2012; 23: 83-83.-14th World Congress on Gastrointestinal Cancer of the European-Society-for-Medical-Oncology (ESMO); JUN 27-30, 2012; Barcelona, SPAIN. [Poster]
Web of Science

 

** Thurner, EM; Krenn-Pilko, S; Renner, W; Gerger, A; Kapp, KS; Langsenlehner, U; Langsenlehner, T Genetic Variants in the TGF-beta 1 Gene and the Risk of Late Toxicity After Radiotherapy in Prostate Cancer Patients
EUR J CANCER. 2012; 48: 87-87.-24th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics; NOV 06-09, 2012; Dublin, IRELAND. Doi: 10.1016/S0959-8049(12)72081-6 [Poster]
Web of Science FullText FullText_MUG

 

** Thurner, EM; Krenn-Pilko, S; Renner, W; Langsenlehner, U; Gerger, A; Kapp, KS; Langsenlehner, T Role of ERCC2 Gene polymorphisms in the development of radiation-induced Late effects in Prostate cancer patients.
Strahlentherapie und Onkologie. 2012; 188(1):107-107.-18. Jahrestagung der Deutschen Gesellschaft für Radioonkologie; JUN 7-10, 2012; Wiesbaden, GERMANY. [Poster]
Web of Science

 

** Thurner, EM; Krenn-Pilko, S; Renner, W; Szkandera, J; Gerger, A; Langsenlehner, U; Kapp, KS; Langsenlehner, T; Role of Polymorphisms in the ERCC2 Gene in the Development of Severe Side Effects After Radiotherapy of Prostate Cancer Patients.
EUR J CANCER. EUROPEAN JOURNAL OF CANCER48: S271-S271. OXFORD: ELSEVIER SCI LTD; ( Presented at: 22nd Biennial Congress of the European-Association-for-Cancer-Research, Barcelona, SPAIN, JUL 07-10, 2012) Doi: 10.1016/S0959-8049(12)71727-6 [Poster]
Web of Science FullText FullText_MUG

 

Abstract (Proceedings)

** Krenn-Pilko, S; Hofmann, G; Renner, W; Gerger, A; Thurner, EM; Kapp, KS; Langsenlehner, U; Langsenlehner, T The role of VEGF Gene Polymorphism in the development of distant metastases in postmenopausal Breast cancer patients.
Strahlentherapie und Onkologie. 2012. 2012; 188(1):65-65.-Jahrestagung der Deutschen Gesellschaft für Radioonkologie; JUN 7-10, 2012; Wiesbaden, GERMANY. (ISBN: 0179-7158 ) [Poster]
Web of Science

 

** Thurner, EM; Krenn-Pilko, S; Absenger, G; Hofmann, G; Gerger, A; Langsenlehner, U; Kapp, KS; Langsenlehner, T Correlations between variants in the ERCC2 gene and the risk of the development of radiation induced late toxicity in prostate cancer patients
Onkologie - International Journal for Cancer Research and Treatment. 2012; 35(6):182-182.-Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaft für Hämatologie und Onkologie; OKT 19-23, 2012; Stuttgart, GERMANY. (ISBN: 978-3-318-02304-6 ) [Oral Communication]
Web of Science

 

2011

Full paper/article (Journal)

** Gerger, A; El-Khoueiry, A; Zhang, W; Yang, D; Singh, H; Bohanes, P; Ning, Y; Winder, T; Labonte, MJ; Wilson, PM; Benhaim, L; Paez, D; El-Khoueiry, R; Absenger, G; Lenz, HJ Pharmacogenetic angiogenesis profiling for first-line Bevacizumab plus oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer.
Clin Cancer Res. 2011; 17(17):5783-5792 Doi: 10.1158/1078-0432.CCR-11-1115 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Gerger, A; Labonte, M; Lenz, HJ Molecular predictors of response to antiangiogenesis therapies.
Cancer J. 2011; 17(2):134-141 Doi: 10.1097/PPO.0b013e318212db3c
Web of Science PubMed FullText FullText_MUG

 

** Gerger, A; Zhang, W; Yang, D; Bohanes, P; Ning, Y; Winder, T; LaBonte, MJ; Wilson, PM; Benhaim, L; Paez, D; El-Khoueiry, R; El-Khoueiry, A; Kahn, M; Lenz, HJ Common cancer stem cell gene variants predict colon cancer recurrence.
Clin Cancer Res. 2011; 17(21):6934-6943 Doi: 10.1158/1078-0432.CCR-11-1180 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Hofmann, G; Langsenlehner, U; Langsenlehner, T; Glehr, M; Gerger, A; Absenger, G; Szkandera, J; Fuerst, F; Samonigg, H; Krippl, P; Renner, W Single nucleotide polymorphisms of integrin alpha-2 and beta-3 genes are not associated with relapse-free and overall survival in colorectal cancer patients.
Anticancer Res. 2011; 31(4):1373-1377
Web of Science PubMed

 

** Koller, S; Wiltgen, M; Ahlgrimm-Siess, V; Weger, W; Hofmann-Wellenhof, R; Richtig, E; Smolle, J; Gerger, A In vivo reflectance confocal microscopy: automated diagnostic image analysis of melanocytic skin tumours.
J Eur Acad Dermatol Venereol. 2011; 25(5):554-558 Doi: 10.1111/j.1468-3083.2010.03834.x
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Langsenlehner, T; Renner, W; Gerger, A; Hofmann, G; Thurner, EM; Kapp, KS; Langsenlehner, U Association between single nucleotide polymorphisms in the gene for XRCC1 and radiation-induced late toxicity in prostate cancer patients.
Radiother Oncol. 2011; 98(3):387-393 Doi: 10.1016/j.radonc.2011.01.021
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Langsenlehner, T; Renner, W; Gerger, A; Hofmann, G; Thurner, EM; Kapp, KS; Langsenlehner, U Impact of VEGF gene polymorphisms and haplotypes on radiation-induced late toxicity in prostate cancer patients.
Strahlenther Onkol. 2011; 187(12):784-791 Doi: 10.1007/s00066-011-1106-4
Web of Science PubMed FullText FullText_MUG

 

** Wiltgen, M; Bloice, M; Koller, S; Hoffmann-Wellenhof, R; Smolle, J; Gerger, A Computer-aided diagnosis of melanocytic skin tumors by use of confocal laser scanning microscopy images.
Anal Quant Cytol Histol. 2011; 33(2):85-100
Web of Science PubMed

 

** Winder, T; Bohanes, P; Zhang, W; Yang, D; Power, DG; Ning, Y; Gerger, A; Wilson, PM; Tang, LH; Shah, M; Lee, AS; Lenz, HJ GRP78 promoter polymorphism rs391957 as potential predictor for clinical outcome in gastric and colorectal cancer patients.
Ann Oncol. 2011; 22(11):2431-2439 Doi: 10.1093/annonc/mdq771 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Winder, T; Ning, Y; Yang, D; Zhang, W; Power, DG; Bohanes, P; Gerger, A; Wilson, PM; Lurje, G; Tang, LH; Shah, M; Lenz, HJ Germline polymorphisms in genes involved in the CD44 signaling pathway are associated with clinical outcome in localized gastric adenocarcinoma.
Int J Cancer. 2011; 129(5):1096-1104 Doi: 10.1002/ijc.25787 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Abstract (Journal)

** Hofmann, G; Langsenlehner, T; Fuerst, F; Gerger, A; Langsenlehner, U; Bitsche, S; Absenger, G; Samonigg, H; Krippl, P; Renner, W RELAPSE-FREE SURVIVAL IN COLORECTAL CANCER PATIENTS IS NOT ASSOCIATED WITH SINGLE NUCLEOTIDE POLYMORPHISMS IN INTEGRIN RECEPTOR SUBUNITS
ANN ONCOL. 2011; 22: v109-v109.-ESMO 13th World Congress on Gastrointestinal Cancer ; JUN 22-25, 2011; Barcelona, SPAIN. [Poster]
Web of Science

 

** Hofmann, G; Langsenlehner, T; Fuerst, F; Gerger, A; Langsenlehner, U; Szkandera, J; Absenger, G; Samonigg, H; Krippl, P; Renner, W A COMMON HEREDITARY SINGLE NUCLEOTIDE POLYMORPHISM IN THE IN THE GENE OF DEATH RECEPTOR 4 (TNFRSF10A) AND ITS IMPACT ON OVERALL SURVIVAL IN RECTAL CANCER PATIENTS
ANN ONCOL. . 2011; 22: v129-v129.-ESMO 13th World Congress on Gastrointestinal Cancer; JUN 22-25, 2011; Barcelona, SPAIN. [Poster]
Web of Science

 

** Hofmann, G; Langsenlehner, T; Fuerst, F; Gerger, A; Langsenlehner, U; Szkandera, J; Absenger, G; Samonigg, H; Krippl, P; Renner, W Common single nucleotide polymorphisms in the genes of integrin alpha-2 and beta-3 subunits are not associated with overall survival in rectal cancer patients
ONKOLOGIE. 2011; 34: 245-246.-Gemeinsame Jahrestagung 2011 der DGHO, ÖGHO, SGMO und SGH+SSH; SEP 30-OCT 4, 2011; Basel, SWITZERLAND. [Poster]
Web of Science

 

** Thurner, EM; Renner, W; Hofmann, G; Gerger, A; Langsenlehner, U; Kapp, KS; Langsenlehner, T Side effects - Prevention and Management.
STRAHLENTHER ONKOL. 2011; 187(1):78-78. [Oral Communication]
Web of Science

 

** Thurner, EM; Renner, W; Langsenlehner, U; Gerger, A; Hofmann, G; Kapp, K; Langsenlehner, T CORRELATION BETWEEN SINGLE NUCLEOTIDE POLYMORPHISMS IN THE XRCC1 GENE AND THE RISK OF SEVERE SIDE EFFECTS AFTER RADIOTHERAPY FOR PROSTATE CANCER
RADIOTHER ONCOL. 2011; 99: S351-S351. Doi: 10.1016/S0167-8140(11)71035-0
Web of Science FullText FullText_MUG

 

2010

Full paper/article (Journal)

** Gerger, A; Renner, W; Langsenlehner, T; Hofmann, G; Knechtel, G; Szkandera, J; Samonigg, H; Krippl, P; Langsenlehner, U Association of interleukin-10 gene variation with breast cancer prognosis.
Breast Cancer Res Treat. 2010; 119(3):701-705 Doi: 10.1007/s10549-009-0417-y
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Knechtel, G; Hofmann, G; Gerger, A; Renner, W; Langsenlehner, T; Szkandera, J; Wolf, G; Samonigg, H; Krippl, P; Langsenlehner, U Analysis of common germline polymorphisms as prognostic factors in patients with lymph node-positive breast cancer.
J Cancer Res Clin Oncol. 2010; 136(12):1813-1819 Doi: 10.1007/s00432-010-0839-2
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Knechtel, G; Szkandera, J; Stotz, M; Hofmann, G; Langsenlehner, U; Krippl, P; Samonigg, H; Renner, W; Langner, C; Dehchamani, D; Gerger, A Single nucleotide polymorphisms in the hypoxia-inducible factor-1 gene and colorectal cancer risk.
Mol Carcinog. 2010; 49(9):805-809 Doi: 10.1002/mc.20655
Web of Science PubMed FullText FullText_MUG

 

** Richtig, E; Ahlgrimm-Siess, V; Koller, S; Gerger, A; Horn, M; Smolle, J; Hofmann-Wellenhof, R Follow-up of actinic keratoses after shave biopsy by in-vivo reflectance confocal microscopy--a pilot study.
J Eur Acad Dermatol Venereol. 2010; 24(3):293-298 Doi: 10.1111/j.1468-3083.2009.03410.x
Web of Science PubMed FullText FullText_MUG

 

** Szkandera, J; Knechtel, G; Stotz, M; Hofmann, G; Langsenlehner, U; Krippl, P; Langsenlehner, T; Dehchamani, D; Samonigg, H; Renner, W; Gerger, A Association of hypoxia-inducible factor 1-alpha gene polymorphisms and colorectal cancer prognosis.
Anticancer Res. 2010; 30(6):2393-2397
Web of Science PubMed Google Scholar

 

** Szkandera, J; Ploner, F; Bauernhofer, T; Kasparek, AK; Payer, F; Balic, M; Knechtel, G; Gerger, A; Gallè, G; Samonigg, H; Hofmann, G Paraneoplastic limbic encephalitis in a patient with extragonadal choriocarcinoma--significance of onconeural antibodies.
Onkologie. 2010; 33(8-9):452-454 Doi: 10.1159/000317269 (- Case Report)
Web of Science PubMed FullText FullText_MUG

 

** Winder, T; Zhang, W; Yang, D; Ning, Y; Bohanes, P; Gerger, A; Wilson, P; Pohl, A; Mauro, DJ; Langer, C; Rowinsky, EK; Lenz, HJ Germline Polymorphisms in Genes Involved in the IGF1 Pathway Predict Efficacy of Cetuximab in Wild-type KRAS mCRC Patients.
Clin Cancer Res. 2010; 16(22):5591-5602 Doi: 10.1158/1078-0432.CCR-10-2092 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Zhang, W; Azuma, M; Lurje, G; Gordon, MA; Yang, D; Pohl, A; Ning, Y; Bohanes, P; Gerger, A; Winder, T; Hollywood, E; Danenberg, KD; Saltz, L; Lenz, HJ Molecular Predictors of Combination Targeted Therapies (Cetuximab, Bevacizumab) in Irinotecan-Refractory Colorectal Cancer (BOND-2 Study).
Anticancer Res. 2010; 30(10):4209-4217
Web of Science PubMed

 

Abstract (Journal)

** Hofmann, G; Langsenlehner, T; Fuerst, F; Bitsche, S; Gerger, A; Langsenlehner, U; Krippl, P; Renner, W Hereditary variants of VEGF receptor genes and their impact on overall survival in rectal cancer.
Onkologie2010; 33(S 6):174-174.-Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie; OCT 1-5, 2010; Berlin, GERMANY. [Poster]
Web of Science

 

** Hofmann, G; Langsenlehner, T; Fuerst, F; Gerger, A; Langsenlehner, U; Knechtel, G; Samonigg, H; Krippl, P; Renner, W ASSOCIATION OF COMMON SINGLE NUCLEOTIDE POLYMORPHISMS IN INTEGRINS WITH METASTASIS-FREE SURVIVAL IN RECTAL CANCER PATIENTS
Annals of Oncology2010; 21(S 6):59-59.-12th World Congress on Gastrointestinal Cancer; June 30-July 3, 2010; Barcelona, SPAIN. [Poster]
Web of Science

 

** Hofmann, G; Langsenlehner, T; Fuerst, F; Gerger, A; Langsenlehner, U; Knechtel, G; Samonigg, H; Krippl, P; Renner, W COMMON VEGF RECEPTOR GENE POLYMORPHISMS AND THEIR INFLUENCE ON OVERALL SURVIVAL IN COLORECTAL CANCER PATIENTS
Annals of Oncology2010; 21(S 6):35-35.-12th World Congress on Gastrointestinal Cancer; June 30-July 3, 2010; Barcelona, SPAIN. [Poster]
Web of Science

 

** Hofmann, G; Langsenlehner, T; Fuerst, F; Szkandera, J; Gerger, A; Langsenlehner, U; Krippl, P; Renner, W Association of a single nucleotide polymorphism in the gene of TNFRSF10A (TRAILR-1) with relapse-free survival in colorectal cancer.
Onkologie2010; 33(S 6):173-173.-Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie; OCT 1-5, 2010; Berlin, GERMANY. (ISBN: 0378-584X ) [Poster]
Web of Science

 

** Knechtel, G; Szkandera, J; Stotz, M; Hofmann, G; Langsenlehner, U; Krippl, P; Samonigg, H; Renner, W; Dehchamani, D; Gerger, A Single nucleotide polymorphisms in the hypoxia-inducible factor 1 gene and colorectal cancer risk
Onkologie-International Journal for Cancer Research and Treatment2010; 33(S6):225-226.-Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie; OKT 1-5, 2010; Berlin, GERMANY. (ISBN: 978-3-8055-9633-6 ) [Oral Communication]
Web of Science

 

** Szkandera, J; Knechtel, G; Stotz, M; Hofmann, G; Langsenlehner, U; Krippl, P; Langsenlehner, T; Dehchamani, D; Samonigg, H; Renner, W; Gerger, A Association of Hypoxia Inducible Factor 1-alpha Gene Polymorphisms and Colorectal Cancer Prognosis.
Onkologie-International Journal for Cancer Research and Treatment2010; 33(S6):226-226.-Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie; OKT 1-5, 2010; Berlin, GERMANY. (ISBN: 978-3-8055-9633-6 ) [Oral Communication]
Web of Science

 

2009

Full paper/article (Journal)

** Ahlgrimm-Siess, V; Horn, M; Koller, S; Ludwig, R; Gerger, A; Hofmann-Wellenhof, R Monitoring efficacy of cryotherapy for superficial basal cell carcinomas with in vivo reflectance confocal microscopy: A preliminary study.
J Dermatol Sci. 2009; 53(1):60-64 Doi: 10.1016/j.jdermsci.2008.08.005
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Ahlgrimm-Siess, V; Massone, C; Scope, A; Fink-Puches, R; Richtig, E; Wolf, IH; Koller, S; Gerger, A; Smolle, J; Hofmann-Wellenhof, R Reflectance confocal microscopy of facial lentigo maligna and lentigo maligna melanoma: a preliminary study.
Br J Dermatol. 2009; 161(6):1307-1316 Doi: 10.1111/j.1365-2133.2009.09289.x
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Gerger, A; Hofmann, G; Langsenlehner, U; Renner, W; Weitzer, W; Wehrschütz, M; Wascher, T; Samonigg, H; Krippl, P Integrin alpha-2 and beta-3 gene polymorphisms and colorectal cancer risk.
Int J Colorectal Dis. 2009; 24(2):159-163 Doi: 10.1007/s00384-008-0587-9
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Gerger, A; Hofmann-Wellenhof, R; Samonigg, H; Smolle, J In vivo confocal laser scanning microscopy in the diagnosis of melanocytic skin tumours.
Br J Dermatol. 2009; 160(3):475-481 Doi: 10.1111/j.1365-2133.2008.08995.x
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Hofmann, G; Langsenlehner, U; Langsenlehner, T; Yazdani-Biuki, B; Clar, H; Gerger, A; Fuerst, F; Samonigg, H; Krippl, P; Renner, W A common hereditary single-nucleotide polymorphism in the gene of FAS and colorectal cancer survival.
J Cell Mol Med. 2009; 13(9B):3699-3702 Doi: 10.1111/j.1582-4934.2009.00720.x [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Hofmann-Wellenhof, R; Wurm, EM; Ahlgrimm-Siess, V; Richtig, E; Koller, S; Smolle, J; Gerger, A Reflectance confocal microscopy--state-of-art and research overview.
Semin Cutan Med Surg. 2009; 28(3):172-179 Doi: 10.1016/j.sder.2009.06.004
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Koller, S; Gerger, A; Ahlgrimm-Siess, V; Weger, W; Smolle, J; Hofmann-Wellenhof, R In vivo reflectance confocal microscopy of erythematosquamous skin diseases.
Exp Dermatol. 2009; 18(6):536-540 Doi: 10.1111/j.1600-0625.2008.00822.x
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Koller, S; Horn, M; Weger, W; Massone, C; Smolle, J; Gerger, A Confocal laser scanning microscopy-guided surgery for neurofibroma.
Clin Exp Dermatol. 2009; 34(8):e670-e672 Doi: 10.1111/j.1365-2230.2009.03387.x (- Case Report)
Web of Science PubMed FullText FullText_MUG

 

** Lorber, A; Wiltgen, M; Hofmann-Wellenhof, R; Koller, S; Weger, W; Ahlgrimm-Siess, V; Smolle, J; Gerger, A Correlation of image analysis features and visual morphology in melanocytic skin tumours using in vivo confocal laser scanning microscopy
SKIN RES TECHNOL. 2009; 15(2): 237-241. Doi: 10.1111/j.1600-0846.2009.00361.x
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Richtig, E; Gerger, A; El-Shabrawi-Caelen, L; Szkandera, J; Hofmann-Wellenhof, R Reflectance confocal microscopy in early diagnosis of cutaneous metastases of breast cancer.
Gynecol Oncol. 2009; 115(3):510-511 Doi: 10.1016/j.ygyno.2009.08.030 (- Case Report)
Web of Science PubMed FullText FullText_MUG

 

Abstract (Journal)

** Hofmann, G; Langsenlehner, T; Fuerst, F; Gerger, A; Langsenlehner, U; Knechtel, G; Szkandera, J; Krippl, P; Renner, W The 683A>C polymorphism in the ligand binding domain of TRAILR-1 (TNFRSF10A) is not associated with colorectal cancer survival.
Annals of Oncology2009; 20(S 7):31-31.-11th World Congress on Gastrointestinal Cancer ; JUNE 24-27, 2009; Barcelona, SPAIN. [Poster]
Web of Science

 

** Hofmann, G; Langsenlehner, T; Fuerst, F; Gerger, A; Langsenlehner, U; Samonigg, H; Clar, H; Krippl, P; Renner, W A hereditary single nucleotide polymorphism in the FAS gene and its impact on developing metastases in rectal cancer patients.
Annals of Oncology. 2009; 20(S 7):58-58.-11th World Congress on Gastrointestinal Cancer ; JUNE 24-27; Barcelona, SPAIN. [Poster]
Web of Science

 

** Langsenlehner, T; Partl, R; Tauber, G; Gerger, A; Hofmann, G; Renner, W; Kapp, KS; Langsenlehner, U Single nucleotide polymorphisms in the gene for vascular endothelial growth factor and radiation induced late toxicity
EJC Supplements 20092009; 7(2):155-155.-Joint ECCO15-34th ESMO Multidisciplinary Congress; SEP 20-24, 2009; Berlin, GERMANY. Doi: 10.1016/S1359-6349(09)70528-2 [Oral Communication]
Web of Science FullText FullText_MUG

 

2008

Full paper/article (Journal)

** Ahlgrimm-Siess, V; Massone, C; Koller, S; Fink-Puches, R; Richtig, E; Wolf, I; Gerger, A; Hofmann-Wellenhof, R In vivo confocal scanning laser microscopy of common naevi with globular, homogeneous and reticular pattern in dermoscopy.
Br J Dermatol. 2008; 158(5):1000-1007 Doi: 10.1111/j.1365-2133.2008.08460.x
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Gerger, A; Hofmann-Wellenhof, R; Langsenlehner, U; Richtig, E; Koller, S; Weger, W; Ahlgrimm-Siess, V; Horn, M; Samonigg, H; Smolle, J In vivo confocal laser scanning microscopy of melanocytic skin tumours: diagnostic applicability using unselected tumour images.
Br J Dermatol. 2008; 158(2):329-333 Doi: 10.1111/j.1365-2133.2007.08389.x
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Gerger, A; Wiltgen, M; Langsenlehner, U; Richtig, E; Horn, M; Weger, W; Ahlgrimm-Siess, V; Hofmann-Wellenhof, R; Samonigg, H; Smolle, J Diagnostic image analysis of malignant melanoma in in vivo confocal laser-scanning microscopy: a preliminary study
SKIN RES TECHNOL. 2008; 14(3): 359-363. Doi: 10.1111/j.1600-0846.2008.00303.x
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Hofmann, G; Langsenlehner, U; Renner, W; Langsenlehner, T; Yazdani-Biuki, B; Clar, H; Gerger, A; Wehrschuetz, M; Samonigg, H; Krippl, P Common single nucleotide polymorphisms in the vascular endothelial growth factor gene and colorectal cancer risk.
J Cancer Res Clin Oncol. 2008; 134(5):591-595 Doi: 10.1007/s00432-007-0322-x
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Horn, M; Gerger, A; Ahlgrimm-Siess, V; Weger, W; Koller, S; Kerl, H; Samonigg, H; Smolle, J; Hofmann-Wellenhof, R Discrimination of actinic keratoses from normal skin with reflectance mode confocal microscopy.
Dermatol Surg. 2008; 34(5):620-625 Doi: 10.1111/j.1524-4725.2008.34195.x
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Horn, M; Koller, S; Gerger, A; Weger, W; Kerl, H; Smolle, J Surgery guided by confocal laser scanning microscopy for foreign filler granulomas.
Dermatol Surg. 2008; 34(9):1245-1247 Doi: 10.1111/j.1524-4725.2008.34268.x (- Case Report)
Web of Science PubMed FullText FullText_MUG

 

** Langsenlehner, U; Wolf, G; Langsenlehner, T; Gerger, A; Hofmann, G; Clar, H; Wascher, TC; Paulweber, B; Samonigg, H; Krippl, P; Renner, W Genetic polymorphisms in the vascular endothelial growth factor gene and breast cancer risk. The Austrian "tumor of breast tissue: incidence, genetics, and environmental risk factors" study.
Breast Cancer Res Treat. 2008; 109(2):297-304 Doi: 10.1007/s10549-007-9655-z
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Weger, W; Kränke, B; Gerger, A; Salmhofer, W; Aberer, E Occurrence of subacute cutaneous lupus erythematosus after treatment with fluorouracil and capecitabine.
J Am Acad Dermatol. 2008; 59(2 Suppl 1):S4-S6 Doi: 10.1016/j.jaad.2007.06.040 (- Case Report)
Web of Science PubMed FullText FullText_MUG

 

** Wiltgen, M; Gerger, A; Wagner, C; Smolle, J Automatic identification of diagnostic significant regions in confocal laser scanning microscopy of melanocytic skin tumors.
Methods Inf Med. 2008; 47(1):14-25 Doi: 10.3414/ME0463
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Abstract (Journal)

** Ahlgrimm-Siess, V; Horn, M; Koller, S; Gerger, A; Hofmann-Wellenhof, R Use of in vivo confocal laser scanning microscopy for monitoring of superficial basal cell carcinoma after cryotherapy
EXP DERMATOL. 2008; 17(3):280-280.-ADF Jahrestagung; Feb 28- March 1, 2008; Erlangen, Deutschland. [Poster]
Web of Science

 

** Gerger, A; Langsenlehner, U; Hofmann, G; Samonigg, H; Krippl, P A multigenic approach to predict breast cancer risk
WIEN KLIN WOCHENSCHR. 2008; 120(15-16):A45-A45.-45.-Jahrestagung der österreichischen Gesellschaft für Innere Medizin; Sep 17-20, 2008; Graz, AUSTRIA.. [Poster]
Web of Science

 

** Hofmann, G; Langsenlehner, T; Fuerst, F; Gerger, A; Langsenlehner, U; Samonigg, H; Clar, H; Krippl, P; Renner, W Association of a common-670 A > G polymorphism in the gene of TNFRSF6 (FAS) with overall survival in colorectal cancer patients
ANN ONCOL. 2008; 19(S 6):68-68. [Oral Communication]
Web of Science

 

** Hofmann, G; Langsenlehner, T; Fuerst, F; Gerger, A; Langsenlehner, U; Samonigg, H; Clar, H; Krippl, P; Renner, W Hereditary gene polymorphisms of vascular endothelial growth factor and colorectal cancer.
ANN ONCOL. 2008; 19(S6):68-68.-10th World Congress on Gastrointestinal Cancer; JUNE 25-28, 2008; Barcelona, SPAIN. [Poster]
Web of Science

 

** Horn, M; Koller, S; Weger, W; Gerger, A; Kerl, H; Hofmann-Wellenhof, R Confocal laserscanning guided surgery in the therapy of dermatofibrosarcoma protuberans.
. 2008; 128(S1): S73-S73. [Poster]
Web of Science

 

** Koller, S; Ahlgrimm-Siess, V; Gerger, A; Smolle, J; Hofmann-Wellenhof, R In vivo confocal laser-scanning microscopy of inflammatory skin diseases
EXP DERMATOL. 2008; 17(3):266-266.-ADF Jahrestagung; Feb 28-Mar 1, 2008; Erlangen, Deutschland. [Poster]
Web of Science

 

2007

Full paper/article (Journal)

** Gerger, A; Langsenlehner, U; Renner, W; Weitzer, W; Eder, T; Yazdani-Biuki, B; Hofmann, G; Samonigg, H; Krippl, P A multigenic approach to predict breast cancer risk.
Breast Cancer Res Treat. 2007; 104(2):159-164 Doi: 10.1007/s10549-006-9408-4
Web of Science PubMed FullText FullText_MUG

 

** Gerger, A; Smolle-Jüttner, FM; Samonigg, H; Wehrschütz, M; Smolle, J Asymptomatic primary malignant melanoma of the esophagus.
Onkologie. 2007; 30(4):206-208 Doi: 10.1159/000099987 (- Case Report)
Web of Science PubMed FullText FullText_MUG

 

** Horn, M; Gerger, A; Koller, S; Weger, W; Langsenlehner, U; Krippl, P; Kerl, H; Samonigg, H; Smolle, J The use of confocal laser-scanning microscopy in microsurgery for invasive squamous cell carcinoma.
Br J Dermatol. 2007; 156(1): 81-84. Doi: 10.1111/j.1365-2133.2006.07574.x
Web of Science PubMed FullText FullText_MUG

 

** Richtig, E; Berghold, A; Schwantzer, G; Ott, A; Wölfelmaier, F; Karner, B; Ludwig, R; Denk, H; Stering, R; Leitner, G; Lax, S; Okcu, M; Gerger, A; Kerl, H; Smolle, J Clinical epidemiology of invasive cutaneous malignant melanoma in the Austrian province Styria in the years 2001-2003 and its relationship with local geographical, meteorological and economic data.
Dermatology. 2007; 214(3):246-252 Doi: 10.1159/000099590
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Richtig, E; Gerger, A; Berghold, A; Schwantzer, G; Ott, A; Kerl, H; Smolle, J Natural history of invasive cutaneous melanoma in Styria, Austria 2001-2003.
J Dtsch Dermatol Ges. 2007; 5(4): 293-299. Doi: 10.1111/j.1610-0387.2007.06246.x
PubMed FullText FullText_MUG Google Scholar

 

** Wiltgen, M; Gerger, A; Wagner, C; Bergthaler, P; Smolle, J Evaluation of texture features in spatial and frequency domain for automatic discrimination of histologic tissue.
Anal Quant Cytol Histol. 2007; 29(4):251-263
Web of Science PubMed Google Scholar

 

Abstract (Journal)

** Gerger, A; Hofmann-Wellenhof, R; Langsenlehner, U; Koller, S; Weger, W; Richtig, E; Horn, M; Samonigg, H; Smolle, J In vivo confocal laser-scanning microscopy: bringing melanoma histopathology to the bedside.
J Invest Dermatol; 2007; 127(S2):S49-S49.-37 th Annual ESDR Meeting; SEP 5-8, 2007; Zürich, Switzerland. [Poster]
Web of Science

 

** Hofmann, G; Gerger, A; Weitzer, W; Langsenlehner, T; Fuerst, F; Renner, W; Samonigg, H; Krippl, P; Langsenlehner, U The ITGA2 807C > T polymorphism is associated with reduced colorectal cancer susceptibility
ANN ONCOL. 2007; 18: VII38-VII38.-2007 World Congress on Gastrointestinal Cancer; JUN 27-30, 2007; Barcelona, SPAIN. [Poster]
Web of Science

 

** Hofmann-Wellenhof, R; Ahlgrimm-Siess, V; Fink-Puches, R; Richtig, E; Wolf, IH; Gerger, A; Smolle, J; Kerl, H In vivo Confocal laser scanning microscopy of equivocal pigmented skin lesions
J INVEST DERMATOL. 2007; 127: S25-S25.-The 37th Meeting of the European Society for Dermatological Research (ESDR); 5-9 September 2007; Zürich. [Oral Communication]
Web of Science

 

** Horn, M; Gerger, A; Ahlgrimm-Siess, V; Weger, W; Koller, S; Kerl, H; Samonigg, H; Smolle, J; Hofmann-Wellenhof, R Diagnostic in vivo confocal laser-scanning microscopy of actinic keratoses
J INVEST DERMATOL. ; 127: S41-S41.-68th Annual Meeting of the Society for Investigative Dermatology; May 9-12, 2007; Los Angeles, USA. [Poster]
Web of Science

 

** Horn, M; Gerger, A; Wiltgen, M; Langsenlehner, U; Hofmann-Wellenhof, R; Weger, W; Richtig, E; Samonigg, H; Smolle, J Diagnostic image analysis of malignant melanoma in in-vivo confocal laser-scanning microscopy.
J Invest Dermatol;2007; 127(S2):S91-S91.-37 th Annual ESDR Meeting; SEP 5-8, 2007; Zürich, Switzerland. [Poster]
Web of Science

 

** Langsenlehner, T; Gerger, A; Hofmann, G; Kapp, KS; Langsenlehner, U Genetic polymorphisms in the vascular endothelial growth factor (VEGF) gene and breast cancer risk
BREAST CANCER RES TREAT. 2007; 106: S286-S286.-SABCS; DEC 13-16, 2007; San Antonio, Texas, USA. [Oral Communication]
Web of Science

 

** Langsenlehner, T; Hofmann, G; Gerger, A; Kapp, KS; Langsenlehner, U The association between the MTHFR 677C>T polymorphism and breast cancer risk in premenopausal women.
Eur J Cancer Supplements2007; 5(4):100-100.-ECCO 14; SEP 23-27, 2007; Barcelona, . [Oral Communication]
Web of Science

 

Comment

** Langsenlehner, U; Gerger, A; Weitzer, W; Krippl, P COX-2 expression in canine and feline invasive mammary carcinomas: correlation with clinicopathological features and prognostic for molecular markers.
Breast Cancer Res Treat. 2007; 101(2): 247-247. Doi: 10.1007/s10549-006-9291-z
Web of Science PubMed FullText FullText_MUG

 

2006

Full paper/article (Journal)

** Gerger, A; Koller, S; Weger, W; Richtig, E; Kerl, H; Samonigg, H; Krippl, P; Smolle, J Sensitivity and specificity of confocal laser-scanning microscopy for in vivo diagnosis of malignant skin tumors.
Cancer. 2006; 107(1): 193-200. Doi: 10.1002/cncr.21910 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Pressetext

 

Abstract (Journal)

** Gerger, A; Horn, M; Samonigg, H; Langsenlehner, U; Krippl, P; Kerl, H; Smolle, J Diagnostic virtual histopathology of untreated fresh specimens from squamous cell carcinoma using confocal laser-scanning microscopy
J INVEST DERMATOL. 126: 114-114.-European Society of Dermatological Research; Sep, 2006; Paris, France. [Oral Communication]
Web of Science

 

** Gerger, A; Kerl, H; Samonigg, H; Langsenlehner, U; Krippl, P; Smolle, J Sensitivity and specificity of confocal laser scanning microscopy for in vivo diagnosis of malignant skin tumors
J INVEST DERMATOL. 126: 114-114.-European Society of Dermatological Research; Sep, 2006; Paris, France. [Poster]
Web of Science

 

** Langsenlehner, U; Eder, T; Renner, W; Gerger, A; Hofmann, G; Samonigg, H; Krippl, P The cyclooxygenase-2 (PTGS2) 8473T > C polymorphism increases breast cancer risk.
BREAST CANCER RES TREAT. 2006; 100: S251-S252.-29th Annual San Antonio Breast Cancer Symposium; DEC 14-17, 2006; San Antonio, USA. [Poster]
Web of Science

 

2005

Full paper/article (Journal)

** Gerger, A; Horn, M; Koller, S; Weger, W; Massone, C; Leinweber, B; Kerl, H; Smolle, J Confocal examination of untreated fresh specimens from basal cell carcinoma: implications for microscopically guided surgery.
ARCH DERMATOL. 2005; 141(10): 1269-1274. Doi: 10.1001/archderm.141.10.1269 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Gerger, A; Koller, S; Kern, T; Massone, C; Steiger, K; Richtig, E; Kerl, H; Smolle, J Diagnostic applicability of in vivo confocal laser scanning microscopy in melanocytic skin tumors.
J INVEST DERMATOL. 2005; 124(3): 493-498. Doi: 10.1111/j.0022-202X.2004.23569.x [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Abstract (Journal)

** Gerger, A; Horn, M; Koller, S; Weger, W; Massone, C; Leinweber, B; Kerl, H; Smolle, J Confocal examination of untreated fresh specimens from basal cell carcinoma: Implications for microscopically guided surgery
J INVEST DERMATOL 2005 125: A87-A87.
Web of Science

 

2004

Full paper/article (Journal)

** Gerger, A; Bergthaler, P; Smolle, J An automated method for the quantification and fractal analysis of immunostaining.
CELL ONCOL. 2004; 26: 125-134. Doi: 10.1155/2004/241921 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Wiltgen, M; Gerger, A; Wagner, C; Bergthaler, P; Smolle, J Evaluation of the influence of image compression to the automatic discrimination of histological images of skin lesions.
METHODS INFORM MED. 2004; 43: 141-149. Doi: 10.1267/METH04020141
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Abstract (Journal)

** Gerger, A; Koller, S; Steiger, K; Massone, C; Kern, T; Richtig, E; Smolle, J Diagnostic applicability of in vivo confocal laser scanning microscopy in melanocytic skin tumors
J INVEST DERMATOL 2004 123: -.
Web of Science

 

** Gerger, A; Wiltgen, M; Smolle, J Tissue counter analysis - A novel tool for the fully automated analysis of complex tissue scenes
CYTOMETRY PART A 2004 59A: 39-40.
Web of Science

 

** Kolm, I; Di Stefani, A; Zalaudek, I; Fink-Puches, R; Wolf, IH; Richtig, E; Gerger, A; Smolle, J; Kerl, H; Hofmann-Wellenhof, R Dermoscopic classification and follow-up of halo nevi
J INVEST DERMATOL 2004 123: 395-395.
Web of Science

 

2003

Full paper/article (Journal)

** Gerger, A; Pompl, R; Smolle, J; Wilhelm Stolz Automated epiluminescence microscopy--tissue counter analysis using CART and 1-NN in the diagnosis of Melanoma.
SKIN RES TECHNOL 2003 9: 105-110. Doi: 10.1034/j.1600-0846.2003.00028.x
Web of Science PubMed FullText FullText_MUG

 

** Gerger, A; Smolle, J Diagnostic tissue elements in melanocytic skin tumors in automated image analysis.
AMER J DERMATOPATHOL 2003 25: 100-106. Doi: 10.1097%2F00000372-200304000-00002
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Gerger, A; Smolle, J Diagnostic imaging of melanocytic skin tumors.
J CUTANEOUS PATHOL 2003 30: 247-252. Doi: 10.1046/j.0303-6987.2003.044.x [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Smolle, J; Gerger, A Tissue counter analysis of tissue components in skin biopsies: evaluation using CART (Classification and Regression Trees).
AMER J DERMATOPATHOL 2003 25: 215-222. Doi: 10.1097%2F00000372-200306000-00006
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Wiltgen, M; Gerger, A; Smolle, J Tissue counter analysis of benign common nevi and malignant melanoma.
INT J MED INFORM 2003 69: 17-28. Doi: 10.1016%2FS1386-5056%2802%2900049-7
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Wiltgen, M; Gerger, A; Wagner, C; Bergthaler, P; Smolle, J Discrimination of benign common nevi from malignant melanoma lesions by use of features based on spectral properties of the wavelet transform.
ANAL QUANT CYTOL HISTOL 2003 25: 243-253.
Web of Science PubMed Google Scholar

 

2002

Full paper/article (Journal)

** Smolle, J; Gerger, A; Weger, W; Kutzner, H; Tronnier, M Tissue counter analysis of histologic sections of melanoma: influence of mask size and shape, feature selection, statistical methods and tissue preparation.
ANAL CELL PATHOL 2002 24: 59-67. Doi: 10.1155/2002/141295 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Abstract (Journal)

** Gerger, A; Smolle, J Automated epiluminescence microscopy - tissue counter analysis using CART and 1-NN in the diagnosis of melanoma
EXP DERMATOL 2002 11: 607-608.
Web of Science

 

** Gerger, A; Smolle, J Morphometric diagnosis of histologic sections of melanocytic skin tumors in automated image analysis
J INVEST DERMATOL 2002 119: 767-767.
Web of Science

 

** Smolle, J; Paar, G; Gerger, A; Lechner, G; Sidla, O Skin mapping using low cost stereo vision
J INVEST DERMATOL 2002 119: 766-766.
Web of Science

 

** Wiltgen, M; Gerger, A; Smolle, J Tissue counter analysis: discrimination of benign common nevi and malignant melanoma with features from histogram and co-occurrence matrix
EXP DERMATOL, 11, 608-609, 0906-6705 Doi: 10.1034/j.1600-0625.2002.110613.x
Web of Science FullText FullText_MUG

 

2001

Abstract (Journal)

** Smolle, J; Gerger, A Tissue counter analysis of tissue components in skin biopsies - Evaluation using CART (classification and regression trees)
J INVEST DERMATOL 2001 117: 791-791.
Web of Science

 

↑ Top of page / Navigation

© Med Uni Graz • Imprint